Pål Aukrust
Position: Professor
Phone:
Email:
 

Curriculum vitae

 

1.                  Education and Academic Degrees

  • M.D. at University of Bergen 1981.
  • PhD at the University of Oslo 1996. Thesis entitled "Role of tumor necrosis factor and oxidative stress in the immunopathogenesis of human immunodeficiency".
  • Specialist in Internal Medicine, 1992.
  • Specialist in Infectious Diseases, 2003.

2.                  Present Position

  • Senior Consultant at Section of Clinical Immunology and Infectious Diseases, Rikshospitalet, University of Oslo, Oslo.
  • In the leadership of the thematic research group "Chronic inflammation in the pathogenesis of human disease", University of Oslo.
  • Professor at Research Institute of Internal Medicine, Rikshospitalet, University of Oslo, Oslo..

3.                  Research experience

  • 306 PubMed registered scientific publications.
  • More than 180 publications in journals with Impact Factor above 5, 50 in journals with Impact Factor above 9.
  • H index of 41.
  • Approx. 180 abstracts at International scientific congresses.
  • Postdoctoral Fellowship from the Research Council of Norway (1997-98)."The pathogenic role of TNF and oxidative stress in human immunodeficiency".
  • From 1996 supervision of 28 PhD candidates at the University of Oslo.
  • From 2002 supervision of 4 postdoctoral researchers at the University of Oslo.
  • Regular Reviewer in several international scientific journals including Lancet, Blood, FASEB J, Circulation, J Am Coll Cardiol, Arterioscler Thromb Vasc Biol, AIDS, J Infect Dis, Eur Heart J, Cardiovasc Res, Thromb Haemost, Eur J Heart Fail, Am J Cardiol, Am Heart J, Atherosclerosis, and Heart.
  • Editorial Consultant in J Am Coll Cardiol (2004-).

4.                  Teaching experience

  • Teaching of medical students at University of Oslo (1998-2002).
  • Organizing of 5 postgraduate courses at University of Oslo.
  • Teaching at 70 postgraduate courses at University of Oslo.

 

 

Author network for Pål Aukrust by COREMINE medical


Publications in press

Arora S, Aarones M, Aakhus S, Skaardal R, Aass H, Aukrust P, Kongsgaard E, Gullestad L
Peak oxygen uptake during cardiopulmonary exercise testing determines response to cardiac resynchronization therapy
J Cardiol (in press)
PubMed 22542140

Bliksøen M, Mariero LH, Ohm IK, Haugen F, Yndestad A, Solheim S, Seljeflot I, Ranheim T, Andersen GO, Aukrust P, Valen G, Vinge LE
Increased circulating mitochondrial DNA after myocardial infarction
Int J Cardiol (in press)
PubMed 22578950

Dahl TB, Holm S, Aukrust P, Halvorsen B
Visfatin/NAMPT: A Multifaceted Molecule with Diverse Roles in Physiology and Pathophysiology
Annu Rev Nutr (in press)
PubMed 22462624

Gullestad L, Ueland T, Kjekshus J, Nymo SH, Hulthe J, Muntendam P, Adourian A, Böhm M, van Veldhuisen DJ, Komajda M, Cleland JG, Wikstrand J, McMurray JJ, Aukrust P, on behalf of the CORONA Study Group
Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
Eur Heart J (in press)
PubMed 22513778

Manhenke C, Orn S, von Haehling S, Wollert KC, Ueland T, Aukrust P, Voors AA, Squire I, Zannad F, Anker SD, Dickstein K
Clustering of 37 circulating biomarkers by exploratory factor analysis in patients following complicated acute myocardial infarction
Int J Cardiol (in press)
PubMed 22197217

Orn S, Ueland T, Manhenke C, Sandanger O, Godang K, Yndestad A, Mollnes TE, Dickstein K, Aukrust P
Increased interleukin-1? levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention
J Intern Med (in press)
PubMed 22243053

Solberg OG, Ueland T, Wergeland R, Dahl CP, Aakhus S, Aukrust P, Gullestad L
High-sensitive troponin T and N-terminal-brain-natriuretic-peptide predict outcome in symptomatic aortic stenosis
Scand Cardiovasc J (in press)
PubMed 22545649

Ueland T, Aukrust P, Aakhus S, Smith C, Endresen K, Birkeland KI, Gullestad L, Johansen OE
Activin A and cardiovascular disease in type 2 diabetes mellitus
Diab Vasc Dis Res (in press)
PubMed 22234949

Publications 2012

Abbas A, Aukrust P, Dahl TB, Bjerkeli V, Sagen EB, Michelsen A, Russell D, Sørensen KK, Holm S, Skjelland M, Halvorsen B (2012)
High levels of S100A12 are associated with recent plaque symptomatology in patients with carotid atherosclerosis
Stroke, 43 (5), 1347-53
PubMed 22382154

Arora S, Gude E, Sigurdardottir V, Mortensen SA, Eiskjaer H, Riise G, Mared L, Bjortuft O, Ekmehag B, Jansson K, Simonsen S, Aukrust P, Solbu D, Iversen M, Gullestad L (2012)
Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: The significance of baseline glomerular filtration rate
J. Heart Lung Transplant., 31 (3), 259-265

Broch K, Eek C, Wergeland R, Ueland T, Skårdal R, Aukrust P, Skulstad H, Gullestad L (2012)
NT-proBNP predicts myocardial recovery after non-ST-elevation acute coronary syndrome
Scand Cardiovasc J, 46 (2), 65-71
PubMed 22191851

Broch K, Ueland T, Nymo SH, Kjekshus J, Hulthe J, Muntendam P, McMurray JJ, Wikstrand J, Cleland JG, Aukrust P, Gullestad L (2012)
Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology
Eur J Heart Fail, 14 (3), 268-77
PubMed 22302661

Damås JK, Bækken M, Ueland T, Manner IW, Os I, Yndestad A, Flo TH, Øktedalen O, Aukrust P (2012)
Serum levels of neutrophil gelatinase-associated lipocalin are associated with microalbuminuria in HIV-infected patients
J Acquir Immune Defic Syndr, 59 (2), e24-5
PubMed 22245717

Damås JK, Øktedalen O, Ueland T, Landrø L, Barstad J, Müller F, Frøland SS, Flo TH, Aukrust P (2012)
Enhanced levels of CCL19 in patients with advanced acquired immune deficiency syndrome (AIDS)
Clin Exp Immunol, 167 (3), 492-8
PubMed 22288592

Grub C, Brunborg C, Hasseltvedt V, Aukrust P, Førre O, Almdahl SM, Hollan I (2012)
Antibodies to common infectious agents in coronary artery disease patients with and without rheumatic conditions
Rheumatology (Oxford), 51 (4), 679-85
PubMed 22157685

Haukeland JW, Dahl TB, Yndestad A, Gladhaug IP, Løberg EM, Haaland T, Konopski Z, Wium C, Aasheim ET, Johansen OE, Aukrust P, Halvorsen B, Birkeland KI (2012)
Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies
Eur J Endocrinol, 166 (3), 503-10
PubMed 22170794

Liani R, Halvorsen B, Sestili S, Handberg A, Santilli F, Vazzana N, Formoso G, Aukrust P, Davi G (2012)
Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients
Free Radic. Biol. Med., 52 (8), 1318-1324

Nymo SH, Ueland T, Askevold ET, Flo TH, Kjekshus J, Hulthe J, Wikstrand J, McMurray J, Van Veldhuisen DJ, Gullestad L, Aukrust P, Yndestad A (2012)
The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*
J Intern Med, 271 (5), 436-443
PubMed 22211640

Olarescu NC, Ueland T, Lekva T, Dahl TB, Halvorsen B, Aukrust P, Bollerslev J (2012)
Adipocytes as a Source of Increased Circulating Levels of Nicotinamide Phosphoribosyltransferase/Visfatin in Active Acromegaly
J. Clin. Endocrinol. Metab., 97 (4), 1355-1362

Saure EW, Eagan TM, Jensen RL, Voll-Aanerud M, Aukrust P, Bakke PS, Hardie JA (2012)
Explained variance for blood gases in a population with COPD
Clin Respir J, 6 (2), 72-80
PubMed 21812941

Ueland T, Smedbakken LM, Hallén J, Atar D, Januzzi JL, Halvorsen B, Jensen JK, Aukrust P (2012)
Soluble CXCL16 and long-term outcome in acute ischemic stroke
Atherosclerosis, 220 (1), 244-9
PubMed 22055341

Ueland T, Yndestad A, Dahl CP, Gullestad L, Aukrust P (2012)
TNF Revisited: Osteoprotegerin and TNF-related Molecules in Heart Failure
Curr Heart Fail Rep, 9 (2), 92-100
PubMed 22453763

Waehre A, Vistnes M, Sjaastad I, Nygard S, Husberg C, Lunde IG, Aukrust P, Yndestad A, Vinge LE, Behmen D, Neukamm C, Brun H, Thaulow E, Christensen G (2012)
Chemokines regulate small leucine-rich proteoglycans in the extracellular matrix of the pressure-overloaded right ventricle
J. Appl. Physiol., 112 (8), 1372-1382

Waatevik M, Johannessen A, Hardie JA, Bjordal JM, Aukrust P, Bakke PS, Eagan TM (2012)
Different COPD Disease Characteristics are Related to Different Outcomes in the 6-minute Walk Test
COPD, 9 (3), 227-34
PubMed 22497532

Yndestad A, Finsen AV, Ueland T, Husberg C, Dahl CP, Øie E, Vinge LE, Sjaastad I, Sandanger Ø, Ranheim T, Dickstein K, Kjekshus J, Damås JK, Fiane AE, Hilfiker-Kleiner D, Lipp M, Gullestad L, Christensen G, Aukrust P (2012)
The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failure
PLoS One, 7 (3), e33038
PubMed 22427939

Publications 2011

Andersen GØ, Knudsen EC, Aukrust P, Yndestad A, Oie E, Müller C, Seljeflot I, Ueland T (2011)
Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size
Heart, 97 (6), 460-5
PubMed 21270073

Andersen GØ, Ueland T, Knudsen EC, Scholz H, Yndestad A, Sahraoui A, Smith C, Lekva T, Otterdal K, Halvorsen B, Seljeflot I, Aukrust P (2011)
Activin A levels are associated with abnormal glucose regulation in patients with myocardial infarction: potential counteracting effects of activin A on inflammation
Diabetes, 60 (5), 1544-51
PubMed 21464440

Arora S, Ueland T, Wennerblom B, Sigurdadottir V, Eiskjær H, Bøtker HE, Ekmehag B, Jansson K, Mortensen SA, Saunamaki K, Simonsen S, Gude E, Bendz B, Solbu D, Aukrust P, Gullestad L (2011)
Effect of everolimus introduction on cardiac allograft vasculopathy--results of a randomized, multicenter trial
Transplantation, 92 (2), 235-43
PubMed 21677600

Aukrust P, Sandberg WJ, Otterdal K, Vinge LE, Gullestad L, Yndestad A, Halvorsen B, Ueland T (2011)
Tumor necrosis factor superfamily molecules in acute coronary syndromes
Ann Med, 43 (2), 90-103
PubMed 21039303

Berdal JE, Mollnes TE, Wæhre T, Olstad OK, Halvorsen B, Ueland T, Laake JH, Furuseth MT, Maagaard A, Kjekshus H, Aukrust P, Jonassen CM (2011)
Excessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza
J Infect, 63 (4), 308-16
PubMed 21781987

Brun H, Ueland T, Thaulow E, Damas JK, Yndestad A, Aukrust P, Holmstrøm H (2011)
No inflammatory response related to pulmonary hemodynamics in children with systemic to pulmonary shunts
Congenit Heart Dis, 6 (4), 338-46
PubMed 21450032

Dahl T, Ranheim T, Holm S, Berge R, Aukrust P, Halvorsen B (2011)
Nicotinamide phosphoribosyltransferase and lipid accumulation in macrophages
Eur J Clin Invest, 41 (10), 1098-104
PubMed 21426336

Daissormont IT, Christ A, Temmerman L, Sampedro Millares S, Seijkens T, Manca M, Rousch M, Poggi M, Boon L, van der Loos C, Daemen M, Lutgens E, Halvorsen B, Aukrust P, Janssen E, Biessen EA (2011)
Plasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity
Circ Res, 109 (12), 1387-95
PubMed 22021930

Fosshaug LE, Berge RK, Beitnes JO, Berge K, Vik H, Aukrust P, Gullestad L, Vinge LE, Øie E (2011)
Krill oil attenuates left ventricular dilatation after myocardial infarction in rats
Lipids Health Dis, 10, 245
PubMed 22206454

Gran JT, Midtvedt Ø, Haug S, Aukrust P (2011)
Treatment of Schnitzler's syndrome with anakinra: report of three cases and review of the literature
Scand J Rheumatol, 40 (1), 74-9
PubMed 20936987

Holm S, Ueland T, Dahl TB, Michelsen AE, Skjelland M, Russell D, Nymo SH, Krohg-Sørensen K, Clausen OP, Atar D, Januzzi JL, Aukrust P, Jensen JK, Halvorsen B (2011)
Fatty Acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic stroke
PLoS One, 6 (12), e28785
PubMed 22174896

Hope S, Dieset I, Agartz I, Steen NE, Ueland T, Melle I, Aukrust P, Andreassen OA (2011)
Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia
J Psychiatr Res, 45 (12), 1608-16
PubMed 21889167

Landrø L, Ueland T, Otterdal K, Frøland SS, Aukrust P (2011)
Persistently raised plasma levels of platelet-derived inflammatory mediators in HIV-infected patients during highly active anti-retroviral therapy
J Thromb Haemost, 9 (5), 1075-7
PubMed 21324059

Larsen KO, Yndestad A, Sjaastad I, Løberg EM, Goverud IL, Halvorsen B, Jia J, Andreassen AK, Husberg C, Jonasson S, Lipp M, Christensen G, Aukrust P, Skjønsberg OH (2011)
Lack of CCR7 induces pulmonary hypertension involving perivascular leukocyte infiltration and inflammation
Am J Physiol Lung Cell Mol Physiol, 301 (1), L50-9
PubMed 21498626

Morken T, Bohov P, Skorve J, Ulvik R, Aukrust P, Berge RK, Livden JK (2011)
Anti-inflammatory and hypolipidemic effects of the modified fatty acid tetradecylthioacetic acid in psoriasis--a pilot study
Scand J Clin Lab Invest, 71 (4), 269-73
PubMed 21338276

Munk PS, Breland UM, Aukrust P, Skadberg O, Ueland T, Larsen AI (2011)
Inflammatory response to percutaneous coronary intervention in stable coronary artery disease
J Thromb Thrombolysis, 31 (1), 92-8
PubMed 20373128

Munk PS, Breland UM, Aukrust P, Ueland T, Kvaløy JT, Larsen AI (2011)
High intensity interval training reduces systemic inflammation in post-PCI patients
Eur J Cardiovasc Prev Rehabil, 18 (6), 850-7
PubMed 21450602

Narverud I, Ueland T, Nenseter MS, Retterstøl K, Telle-Hansen VH, Halvorsen B, Ose L, Aukrust P, Holven KB (2011)
Children with familial hypercholesterolemia are characterized by an inflammatory imbalance between the tumor necrosis factor ? system and interleukin-10
Atherosclerosis, 214 (1), 163-8
PubMed 21040915

Orre IJ, Reinertsen KV, Aukrust P, Dahl AA, Fosså SD, Ueland T, Murison R (2011)
Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors
J Psychosom Res, 71 (3), 136-41
PubMed 21843747

Smedbakken L, Jensen JK, Hallén J, Atar D, Januzzi JL, Halvorsen B, Aukrust P, Ueland T (2011)
Activated leukocyte cell adhesion molecule and prognosis in acute ischemic stroke
Stroke, 42 (9), 2453-8
PubMed 21757661

Søyland E, Heier I, Rodríguez-Gallego C, Mollnes TE, Johansen FE, Holven KB, Halvorsen B, Aukrust P, Jahnsen FL, de la Rosa Carrillo D, Krogstad AL, Nenseter MS (2011)
Sun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis
Br J Dermatol, 164 (2), 344-55
PubMed 21271993

Ueland T, Aukrust P, Broch K, Aakhus S, Skårdal R, Muntendam P, Gullestad L (2011)
Galectin-3 in heart failure: high levels are associated with all-cause mortality
Int J Cardiol, 150 (3), 361-4
PubMed 21641051

Ueland T, Aukrust P, Dahl CP, Husebye T, Solberg OG, Tønnessen T, Aakhus S, Gullestad L (2011)
Osteoprotegerin levels predict mortality in patients with symptomatic aortic stenosis
J Intern Med, 270 (5), 452-60
PubMed 21623962

Ueland T, Aukrust P, Omdal TR, Damås JK, Endresen K, Ren F, Hysing J (2011)
Effect of eptifibatide on platelet-mediated inflammation in acute coronary syndromes
Int J Cardiol, 151 (3), 385-7
PubMed 21782261

Ueland T, Dahl CP, Gullestad L, Aakhus S, Broch K, Skårdal R, Vermeer C, Aukrust P, Schurgers LJ (2011)
Circulating levels of non-phosphorylated undercarboxylated matrix Gla protein are associated with disease severity in patients with chronic heart failure
Clin Sci (Lond), 121 (3), 119-27
PubMed 21294711

Ueland T, Dahl CP, Kjekshus J, Hulthe J, Böhm M, Mach F, Goudev A, Lindberg M, Wikstrand J, Aukrust P, Gullestad L (2011)
Osteoprotegerin predicts progression of chronic heart failure: results from CORONA
Circ Heart Fail, 4 (2), 145-52
PubMed 21216833

Ueland T, Jørgensen AP, Godang K, Fougner KJ, Aukrust P, Burman P, Bollerslev J (2011)
Interleukin 1 receptor antagonist is associated with changes in body composition during physiological GH substitution in patients with adult-onset growth hormone deficiency
Clin Endocrinol (Oxf), 74 (1), 60-6
PubMed 21039720

Ueland T, Lekva T, Otterdal K, Dahl TB, Olarescu NC, Jørgensen AP, Fougner KJ, Brixen K, Aukrust P, Bollerslev J (2011)
Increased serum and bone matrix levels of transforming growth factor {beta}1 in patients with GH deficiency in response to GH treatment
Eur J Endocrinol, 165 (3), 393-400
PubMed 21653735

Waehre A, Halvorsen B, Yndestad A, Husberg C, Sjaastad I, Nygård S, Dahl CP, Ahmed MS, Finsen AV, Reims H, Louch WE, Hilfiker-Kleiner D, Vinge LE, Roald B, Attramadal H, Lipp M, Gullestad L, Aukrust P, Christensen G (2011)
Lack of chemokine signaling through CXCR5 causes increased mortality, ventricular dilatation and deranged matrix during cardiac pressure overload
PLoS One, 6 (4), e18668
PubMed 21533157

Yndestad A, Haukeland JW, Dahl TB, Halvorsen B, Aukrust P (2011)
Activin A in nonalcoholic fatty liver disease
Vitam Horm, 85, 323-42
PubMed 21353887

Øie E, Ueland T, Dahl CP, Bohov P, Berge C, Yndestad A, Gullestad L, Aukrust P, Berge RK (2011)
Fatty acid composition in chronic heart failure: low circulating levels of eicosatetraenoic acid and high levels of vaccenic acid are associated with disease severity and mortality
J Intern Med, 270 (3), 263-72
PubMed 21466599

Aarones M, Gullestad L, Aakhus S, Ueland T, Skaardal R, Aass H, Wergeland R, Smith HJ, Aukrust P, Kongsgaard E (2011)
Prognostic value of cardiac troponin T in patients with moderate to severe heart failure scheduled for cardiac resynchronization therapy
Am Heart J, 161 (6), 1031-7
PubMed 21641347

Publications 2010

Arora S, Gunther A, Wennerblom B, Ueland T, Andreassen AK, Gude E, Endresen K, Geiran O, Wilhelmsen N, Andersen R, Aukrust P, Gullestad L (2010)
Systemic markers of inflammation are associated with cardiac allograft vasculopathy and an increased intimal inflammatory component
Am J Transplant, 10 (6), 1428-36
PubMed 20486911

Aukrust P, Halvorsen B, Ueland T, Michelsen AE, Skjelland M, Gullestad L, Yndestad A, Otterdal K (2010)
Activated platelets and atherosclerosis
Expert Rev Cardiovasc Ther, 8 (9), 1297-307
PubMed 20828352

Aukrust P, Yndestad A (2010)
Inadequate Masking of Testosterone Reply
J. Am. Coll. Cardiol., 55 (20), 2291

Baekken M, Manner I, Ueland T, Frøland SS, Os I, Aukrust P, Oktedalen O, Damås JK (2010)
Osteoprotegrin and soluble tumor necrosis factor receptor 1 are associated with microalbuminuria in nontreated HIV-infected patients
J Acquir Immune Defic Syndr, 53 (3), 419-20
PubMed 20190590

Bergestuen DS, Edvardsen T, Aakhus S, Ueland T, Oie E, Vatn M, Aukrust P, Thiis-Evensen E (2010)
Activin A in carcinoid heart disease: a possible role in diagnosis and pathogenesis
Neuroendocrinology, 92 (3), 168-77
PubMed 20720391

Bergestuen DS, Gravning J, Haugaa KH, Sahakyan LG, Aakhus S, Thiis-Evensen E, Øie E, Aukrust P, Attramadal H, Edvardsen T (2010)
Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors
BMC Cancer, 10, 6
PubMed 20053285

Breland UM, Hollan I, Saatvedt K, Almdahl SM, Damås JK, Yndestad A, Mikkelsen K, Førre OT, Aukrust P, Ueland T (2010)
Inflammatory markers in patients with coronary artery disease with and without inflammatory rheumatic disease
Rheumatology (Oxford), 49 (6), 1118-27
PubMed 20231178

Breland UM, Michelsen AE, Skjelland M, Folkersen L, Krohg-Sørensen K, Russell D, Ueland T, Yndestad A, Paulsson-Berne G, Damås JK, Oie E, Hansson GK, Halvorsen B, Aukrust P (2010)
Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation
Cardiovasc Res, 86 (2), 265-73
PubMed 20139115

Caidahl K, Ueland T, Aukrust P (2010)
Osteoprotegerin: a biomarker with many faces
Arterioscler Thromb Vasc Biol, 30 (9), 1684-6
PubMed 20720194

Dahl TB, Haukeland JW, Yndestad A, Ranheim T, Gladhaug IP, Damås JK, Haaland T, Løberg EM, Arntsen B, Birkeland K, Bjøro K, Ulven SM, Konopski Z, Nebb HI, Aukrust P, Halvorsen B (2010)
Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease
J Clin Endocrinol Metab, 95 (6), 3039-47
PubMed 20392873

Eagan TM, Aukrust P, Bakke PS, Damås JK, Skorge TD, Hardie JA, Ueland T, Mollnes TE (2010)
Systemic mannose-binding lectin is not associated with Chronic Obstructive Pulmonary Disease
Respir Med, 104 (2), 283-90
PubMed 19836222

Eagan TM, Aukrust P, Ueland T, Hardie JA, Johannessen A, Mollnes TE, Damås JK, Bakke PS, Wagner PD (2010)
Body composition and plasma levels of inflammatory biomarkers in COPD
Eur Respir J, 36 (5), 1027-33
PubMed 20413541

Eagan TM, Damås JK, Ueland T, Voll-Aanerud M, Mollnes TE, Hardie JA, Bakke PS, Aukrust P (2010)
Neutrophil gelatinase-associated lipocalin: a biomarker in COPD
Chest, 138 (4), 888-95
PubMed 20495108

Eagan TM, Ueland T, Wagner PD, Hardie JA, Mollnes TE, Damås JK, Aukrust P, Bakke PS (2010)
Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study
Eur Respir J, 35 (3), 540-8
PubMed 19643942

Eggum R, Ueland T, Mollnes TE, Videm V, Fiane AE, Aukrust P, Lindberg HL (2010)
Perfusion temperature, thyroid hormones and inflammation during pediatric cardiac surgery
Interact Cardiovasc Thorac Surg, 10 (1), 76-80
PubMed 19822605

Gregersen S, Aaløkken TM, Mynarek G, Fevang B, Holm AM, Ueland T, Aukrust P, Kongerud J, Johansen B, Frøland SS (2010)
Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors
Ann Allergy Asthma Immunol, 104 (6), 503-10
PubMed 20568383

Halvorsen B, Heggen E, Ueland T, Smith C, Sandberg WJ, Damås JK, Otterdal K, Tonstad S, Aukrust P (2010)
Treatment with the PPARgamma agonist rosiglitazone downregulates interleukin-1 receptor antagonist in individuals with metabolic syndrome
Eur J Endocrinol, 162 (2), 267-73
PubMed 19926782

Hoekstra M, van der Lans CA, Halvorsen B, Gullestad L, Kuiper J, Aukrust P, van Berkel TJ, Biessen EA (2010)
The peripheral blood mononuclear cell microRNA signature of coronary artery disease
Biochem Biophys Res Commun, 394 (3), 792-7
PubMed 20230787

Hope S, Melle I, Aukrust P, Agartz I, Lorentzen S, Steen NE, Djurovic S, Ueland T, Andreassen OA (2010)
Osteoprotegerin levels in patients with severe mental disorders
J Psychiatry Neurosci, 35 (5), 304-10
PubMed 20569643

Jensen JK, Aukrust P, Januzzi JL (2010)
Osteoprotegerin and acute ischaemic stroke: reply
J. Intern. Med., 267 (4), 437

Jensen JK, Ueland T, Atar D, Gullestad L, Mickley H, Aukrust P, Januzzi JL (2010)
Osteoprotegerin concentrations and prognosis in acute ischaemic stroke
J Intern Med, 267 (4), 410-7
PubMed 19895657

Michelsen AE, Rathcke CN, Skjelland M, Holm S, Ranheim T, Krohg-Sørensen K, Klingvall MF, Brosstad F, Oie E, Vestergaard H, Aukrust P, Halvorsen B (2010)
Increased YKL-40 expression in patients with carotid atherosclerosis
Atherosclerosis, 211 (2), 589-95
PubMed 20347092

Pedersen ER, Ueland T, Seifert R, Aukrust P, Schartum-Hansen H, Ebbing M, Bleie Ø, Igland J, Svingen G, Nordrehaug JE, Nygård O (2010)
Serum osteoprotegerin levels and long-term prognosis in patients with stable angina pectoris
Atherosclerosis, 212 (2), 644-9
PubMed 20621297

Rødland EK, Ueland T, Pedersen TM, Halvorsen B, Muller F, Aukrust P, Frøland SS (2010)
Activation of platelets by Aspergillus fumigatus and potential role of platelets in the immunopathogenesis of Aspergillosis
Infect Immun, 78 (3), 1269-75
PubMed 20008537

Ueland T, Fougner SL, Godang K, Lekva T, Schurgers LJ, Scholz H, Halvorsen B, Schreiner T, Aukrust P, Bollerslev J (2010)
Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly
J Clin Endocrinol Metab, 95 (1), 361-8
PubMed 19880791

Ueland T, Gullestad L, Dahl CP, Aukrust P, Aakhus S, Solberg OG, Vermeer C, Schurgers LJ (2010)
Undercarboxylated matrix Gla protein is associated with indices of heart failure and mortality in symptomatic aortic stenosis
J Intern Med, 268 (5), 483-92
PubMed 20804515

Wethal T, Haugnes HS, Kjekshus J, Småstuen MC, Ueland T, Aukrust P, Fosså SD (2010)
C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors?
Eur J Cancer, 46 (18), 3425-33
PubMed 20832295

Øie E, Ahmed MS, Ueland T, Sikkeland LI, Dahl CP, Hagelin EM, von Lueder T, Edvardsen T, Andreassen AK, Gullestad L, Aukrust P, Yndestad A, Vinge LE, Attramadal H (2010)
Adrenomedullin is increased in alveolar macrophages and released from the lungs into the circulation in severe heart failure
Basic Res Cardiol, 105 (1), 89-98
PubMed 19823891

Øie E, Sandberg WJ, Ahmed MS, Yndestad A, Lærum OD, Attramadal H, Aukrust P, Eiken HG (2010)
Activation of Notch signaling in cardiomyocytes during post-infarction remodeling
Scand Cardiovasc J, 44 (6), 359-66
PubMed 20799913

Publications 2009

Arora S, Aukrust P, Andreassen A, Simonsen S, Gude E, Grov I, Geiran O, Fiane A, Gullestad L (2009)
The prognostic importance of modifiable risk factors after heart transplantation
Am Heart J, 158 (3), 431-6
PubMed 19699867

Arora S, Aukrust P, Ueland T, Broch K, Simonsen S, Gude E, Fiane AE, Geiran O, Wergeland R, Andreassen AK, Gullestad L (2009)
Elevated serum uric acid levels following heart transplantation predict all-cause and cardiac mortality
Eur J Heart Fail, 11 (10), 1005-13
PubMed 19737803

Aukrust P, Ueland T, Gullestad L, Yndestad A (2009)
Testosterone: a novel therapeutic approach in chronic heart failure?
J Am Coll Cardiol, 54 (10), 928-9
PubMed 19712803

Brun H, Holmstrøm H, Thaulow E, Damås JK, Yndestad A, Aukrust P, Ueland T (2009)
Patients with pulmonary hypertension related to congenital systemic-to-pulmonary shunts are characterized by inflammation involving endothelial cell activation and platelet-mediated inflammation
Congenit Heart Dis, 4 (3), 153-9
PubMed 19489942

Dahl CP, Husberg C, Gullestad L, Waehre A, Damås JK, Vinge LE, Finsen AV, Ueland T, Florholmen G, Aakhus S, Halvorsen B, Aukrust P, Oie E, Yndestad A, Christensen G (2009)
Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling
Circ Heart Fail, 2 (6), 624-32
PubMed 19919988

Damås JK, Davì G, Jensenius M, Santilli F, Otterdal K, Ueland T, Flo TH, Lien E, Espevik T, Frøland SS, Vitale G, Raoult D, Aukrust P (2009)
Relative chemokine and adhesion molecule expression in Mediterranean spotted fever and African tick bite fever
J Infect, 58 (1), 68-75
PubMed 19091423

Damås JK, Landrø L, Fevang B, Heggelund L, Frøland SS, Aukrust P (2009)
Enhanced levels of the CCR7 ligands CCL19 and CCL21 in HIV infection: correlation with viral load, disease progression and response to highly active antiretroviral therapy
AIDS, 23 (1), 135-8
PubMed 19050397

Damås JK, Landrø L, Fevang B, Heggelund L, Tjønnfjord GE, Fløisand Y, Halvorsen B, Frøland SS, Aukrust P (2009)
Homeostatic chemokines CCL19 and CCL21 promote inflammation in human immunodeficiency virus-infected patients with ongoing viral replication
Clin Exp Immunol, 157 (3), 400-7
PubMed 19664149

de Jager SC, Canté-Barrett K, Bot I, Husberg C, van Puijvelde GH, van Santbrink PJ, Yndestad A, van den Oever JM, Kuiper J, van Berkel TJ, Lipp M, Zwaginga JJ, Fibbe WE, Aukrust P, Biessen EA (2009)
Impaired effector memory T-cell regulation facilitates graft versus host disease in CCR7-deficient bone marrow transplant chimeras
Transplantation, 88 (5), 631-9
PubMed 19741459

Fevang B, Eugen-Olsen J, Yndestad A, Brosstad F, Beiske K, Aukrust P, Frøland SS (2009)
Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency
Clin Immunol, 131 (3), 438-46
PubMed 19232508

Fevang B, Yndestad A, Damås JK, Bjerkeli V, Ueland T, Holm AM, Beiske K, Aukrust P, Frøland SS (2009)
Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation
Clin Immunol, 130 (2), 151-61
PubMed 18938112

Fevang B, Yndestad A, Damås JK, Halvorsen B, Holm AM, Beiske K, Aukrust P, Frøland SS (2009)
Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation
Clin Exp Immunol, 158 (2), 237-45
PubMed 19747210

Gregersen S, Aaløkken TM, Mynarek G, Kongerud J, Aukrust P, Frøland SS, Johansen B (2009)
High resolution computed tomography and pulmonary function in common variable immunodeficiency
Respir Med, 103 (6), 873-80
PubMed 19181508

Heymans S, Hirsch E, Anker SD, Aukrust P, Balligand JL, Cohen-Tervaert JW, Drexler H, Filippatos G, Felix SB, Gullestad L, Hilfiker-Kleiner D, Janssens S, Latini R, Neubauer G, Paulus WJ, Pieske B, Ponikowski P, Schroen B, Schultheiss HP, Tschöpe C, Van Bilsen M, Zannad F, McMurray J, Shah AM (2009)
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology
Eur J Heart Fail, 11 (2), 119-29
PubMed 19168509

Hofsø D, Ueland T, Hager H, Jenssen T, Bollerslev J, Godang K, Aukrust P, Røislien J, Hjelmesaeth J (2009)
Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose
Eur J Endocrinol, 161 (3), 451-8
PubMed 19542241

Hope S, Melle I, Aukrust P, Steen NE, Birkenaes AB, Lorentzen S, Agartz I, Ueland T, Andreassen OA (2009)
Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor
Bipolar Disord, 11 (7), 726-34
PubMed 19839997

Jansson AM, Aukrust P, Ueland T, Smith C, Omland T, Hartford M, Caidahl K (2009)
Soluble CXCL16 predicts long-term mortality in acute coronary syndromes
Circulation, 119 (25), 3181-8
PubMed 19528340

Johansen OE, Birkeland KI, Jørgensen AP, Orvik E, Sørgård B, Torjussen BR, Ueland T, Aukrust P, Gullestad L (2009)
Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trial
J Diabetes, 1 (3), 182-7
PubMed 20923537

Kolsgaard ML, Wangensteen T, Brunborg C, Joner G, Holven KB, Halvorsen B, Aukrust P, Tonstad S (2009)
Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome
Scand J Clin Lab Invest, 69 (8), 858-64
PubMed 19929281

Kåsin JI, Kjekshus J, Aukrust P, Mollnes TE, Wagstaff A (2009)
A helicopter flight does not induce significant changes in systemic biomarker profiles
Scand J Clin Lab Invest, 69 (4), 462-74
PubMed 19333819

Landrø L, Damås JK, Halvorsen B, Fevang B, Ueland T, Otterdal K, Heggelund L, Frøland SS, Aukrust P (2009)
CXCL16 in HIV infection - a link between inflammation and viral replication
Eur J Clin Invest, 39 (11), 1017-24
PubMed 19674076

Nenseter MS, Ueland T, Retterstøl K, Strøm E, Mørkrid L, Landaas S, Ose L, Aukrust P, Holven KB (2009)
Dysregulated RANK ligand/RANK axis in hyperhomocysteinemic subjects: effect of treatment with B-vitamins
Stroke, 40 (1), 241-7
PubMed 19008470

Orn S, Breland UM, Mollnes TE, Manhenke C, Dickstein K, Aukrust P, Ueland T (2009)
The chemokine network in relation to infarct size and left ventricular remodeling following acute myocardial infarction
Am J Cardiol, 104 (9), 1179-83
PubMed 19840558

Orre IJ, Murison R, Dahl AA, Ueland T, Aukrust P, Fosså SD (2009)
Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue
Brain Behav Immun, 23 (6), 868-74
PubMed 19362138

Sandanger Ø, Ryan L, Bohnhorst J, Iversen AC, Husebye H, Halaas Ø, Landrø L, Aukrust P, Frøland SS, Elson G, Visintin A, Øktedalen O, Damås JK, Sundan A, Golenbock D, Espevik T (2009)
IL-10 enhances MD-2 and CD14 expression in monocytes and the proteins are increased and correlated in HIV-infected patients
J Immunol, 182 (1), 588-95
PubMed 19109192

Sandberg WJ, Halvorsen B, Yndestad A, Smith C, Otterdal K, Brosstad FR, Frøland SS, Olofsson PS, Damås JK, Gullestad L, Hansson GK, Oie E, Aukrust P (2009)
Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis
Circ Res, 104 (1), 60-8
PubMed 19023130

Sandberg WJ, Otterdal K, Gullestad L, Halvorsen B, Ragnarsson A, Frøland SS, Damås JK, Oie E, Aukrust P, Hansson GK, Yndestad A (2009)
The tumour necrosis factor superfamily ligand APRIL (TNFSF13) is released upon platelet activation and expressed in atherosclerosis
Thromb Haemost, 102 (4), 704-10
PubMed 19806256

Semb AG, Ueland T, Aukrust P, Wareham NJ, Luben R, Gullestad L, Kastelein JJ, Khaw KT, Boekholdt SM (2009)
Osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993-2003
Arterioscler Thromb Vasc Biol, 29 (6), 975-80
PubMed 19325145

Sikkeland LI, Eduard W, Stangeland AM, Thorgersen EB, Haug T, Aukrust P, Halvorsen B, Mollnes TE, Kongerud J (2009)
Occupational exposure to bacterial single cell protein induces inflammation in lung and blood
Inhal Toxicol, 21 (8), 674-81
PubMed 19558225

Tobin KA, Holven KB, Retterstøl K, Strøm E, Ose L, Aukrust P, Nenseter MS (2009)
Cystatin C levels in plasma and peripheral blood mononuclear cells among hyperhomocysteinaemic subjects: effect of treatment with B-vitamins
Br J Nutr, 102 (12), 1783-9
PubMed 19682403

Ueland T, Otterdal K, Lekva T, Halvorsen B, Gabrielsen A, Sandberg WJ, Paulsson-Berne G, Pedersen TM, Folkersen L, Gullestad L, Oie E, Hansson GK, Aukrust P (2009)
Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis
Arterioscler Thromb Vasc Biol, 29 (8), 1228-34
PubMed 19498175

Yndestad A, Haukeland JW, Dahl TB, Bjøro K, Gladhaug IP, Berge C, Damås JK, Haaland T, Løberg EM, Linnestad P, Birkeland K, Konopski Z, Halvorsen B, Berge RK, Aukrust P (2009)
A complex role of activin A in non-alcoholic fatty liver disease
Am J Gastroenterol, 104 (9), 2196-205
PubMed 19532130

Yndestad A, Landrø L, Ueland T, Dahl CP, Flo TH, Vinge LE, Espevik T, Frøland SS, Husberg C, Christensen G, Dickstein K, Kjekshus J, Øie E, Gullestad L, Aukrust P (2009)
Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure
Eur Heart J, 30 (10), 1229-36
PubMed 19329498

Yndestad A, Larsen KO, Oie E, Ueland T, Smith C, Halvorsen B, Sjaastad I, Skjønsberg OH, Pedersen TM, Anfinsen OG, Damås JK, Christensen G, Aukrust P, Andreassen AK (2009)
Elevated levels of activin A in clinical and experimental pulmonary hypertension
J Appl Physiol, 106 (4), 1356-64
PubMed 19196915

Yndestad A, Neurauter CG, Oie E, Forstrøm RJ, Vinge LE, Eide L, Luna L, Aukrust P, Bjørås M (2009)
Up-regulation of myocardial DNA base excision repair activities in experimental heart failure
Mutat Res, 666 (1-2), 32-8
PubMed 19481677

Ørn S, Manhenke C, Ueland T, Damås JK, Mollnes TE, Edvardsen T, Aukrust P, Dickstein K (2009)
C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction
Eur Heart J, 30 (10), 1180-6
PubMed 19299430

Publications 2008

Aukrust P, Halvorsen B, Yndestad A, Ueland T, Øie E, Otterdal K, Gullestad L, Damås JK (2008)
Chemokines and cardiovascular risk
Arterioscler Thromb Vasc Biol, 28 (11), 1909-19
PubMed 18669888

Aukrust P, Otterdal K, Yndestad A, Sandberg WJ, Smith C, Ueland T, Øie E, Damås JK, Gullestad L, Halvorsen B (2008)
The complex role of T-cell-based immunity in atherosclerosis
Curr Atheroscler Rep, 10 (3), 236-43
PubMed 18489852

Bjørnstad HH, Bruvik J, Bjørnstad AB, Hjellestad BL, Damås JK, Aukrust P (2008)
Exercise training decreases plasma levels of soluble CD40 ligand and P-selectin in patients with chronic heart failure
Eur J Cardiovasc Prev Rehabil, 15 (1), 43-8
PubMed 18277184

Breland UM, Halvorsen B, Hol J, Øie E, Paulsson-Berne G, Yndestad A, Smith C, Otterdal K, Hedin U, Waehre T, Sandberg WJ, Frøland SS, Haraldsen G, Gullestad L, Damås JK, Hansson GK, Aukrust P (2008)
A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization: downregulatory effects of statins
Arterioscler Thromb Vasc Biol, 28 (5), 1005-11
PubMed 18276907

Bryn T, Mahic M, Aandahl EM, Frøland SS, Aukrust P, Taskén K (2008)
Inhibition of protein kinase A improves effector function of monocytes from HIV-infected patients
AIDS Res Hum Retroviruses, 24 (7), 1013-5
PubMed 18593346

Dahl CP, Gullestad L, Fevang B, Holm AM, Landrø L, Vinge LE, Fiane AE, Sandberg WJ, Otterdal K, Frøland SS, Damås JK, Halvorsen B, Aukrust P, Øie E, Yndestad A (2008)
Increased expression of LIGHT/TNFSF14 and its receptors in experimental and clinical heart failure
Eur J Heart Fail, 10 (4), 352-9
PubMed 18353719

Eggum R, Ueland T, Mollnes TE, Videm V, Aukrust P, Fiane AE, Lindberg HL (2008)
Effect of perfusion temperature on the inflammatory response during pediatric cardiac surgery
Ann Thorac Surg, 85 (2), 611-7
PubMed 18222275

Halvorsen B, Otterdal K, Dahl TB, Skjelland M, Gullestad L, Øie E, Aukrust P (2008)
Atherosclerotic plaque stability--what determines the fate of a plaque?
Prog Cardiovasc Dis, 51 (3), 183-94
PubMed 19026853

Handberg A, Skjelland M, Michelsen AE, Sagen EL, Krohg-Sørensen K, Russell D, Dahl A, Ueland T, Oie E, Aukrust P, Halvorsen B (2008)
Soluble CD36 in plasma is increased in patients with symptomatic atherosclerotic carotid plaques and is related to plaque instability
Stroke, 39 (11), 3092-5
PubMed 18723424

Herrman H, Braekhus A, Aaserud O, Aukrust P, Stubhaug A, Hassel B (2008)
Early treatment of tetanus-induced trismus with botulinum toxin A
Anesth Analg, 106 (5), 1591
PubMed 18420892

Holven KB, Aukrust P, Retterstøl K, Otterdal K, Bjerkeli V, Ose L, Nenseter MS, Halvorsen B (2008)
The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjects
J Nutr, 138 (11), 2070-5
PubMed 18936200

Husberg C, Nygård S, Finsen AV, Damås JK, Frigessi A, Oie E, Waehre A, Gullestad L, Aukrust P, Yndestad A, Christensen G (2008)
Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure
J Mol Cell Cardiol, 45 (2), 261-9
PubMed 18585734

Kristo C, Ueland T, Godang K, Aukrust P, Bollerslev J (2008)
Biochemical markers for cardiovascular risk following treatment in endogenous Cushing's syndrome
J Endocrinol Invest, 31 (5), 400-5
PubMed 18560257

Landrø L, Damås JK, Flo TH, Heggelund L, Ueland T, Tjønnfjord GE, Espevik T, Aukrust P, Frøland SS (2008)
Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy
Clin Exp Immunol, 152 (1), 57-63
PubMed 18241231

Olofsson PS, Söderström LA, Wågsäter D, Sheikine Y, Ocaya P, Lang F, Rabu C, Chen L, Rudling M, Aukrust P, Hedin U, Paulsson-Berne G, Sirsjö A, Hansson GK (2008)
CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice
Circulation, 117 (10), 1292-301
PubMed 18285570

Omland T, Ueland T, Jansson AM, Persson A, Karlsson T, Smith C, Herlitz J, Aukrust P, Hartford M, Caidahl K (2008)
Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes
J Am Coll Cardiol, 51 (6), 627-33
PubMed 18261681

Otterdal K, Andreassen AK, Yndestad A, Oie E, Sandberg WJ, Dahl CP, Pedersen TM, Ueland T, Gullestad L, Brosstad FR, Aukrust P, Damås JK (2008)
Raised LIGHT levels in pulmonary arterial hypertension: potential role in thrombus formation
Am J Respir Crit Care Med, 177 (2), 202-7
PubMed 17962639

Risnes I, Wagner K, Ueland T, Mollnes T, Aukrust P, Svennevig J (2008)
Interleukin-6 may predict survival in extracorporeal membrane oxygenation treatment
Perfusion, 23 (3), 173-8
PubMed 19029268

Rolseth V, Rundén-Pran E, Neurauter CG, Yndestad A, Luna L, Aukrust P, Ottersen OP, Bjørås M (2008)
Base excision repair activities in organotypic hippocampal slice cultures exposed to oxygen and glucose deprivation
DNA Repair (Amst), 7 (6), 869-78
PubMed 18406215

Smith C, Halvorsen B, Otterdal K, Waehre T, Yndestad A, Fevang B, Sandberg WJ, Breland UM, Frøland SS, Oie E, Gullestad L, Damås JK, Aukrust P (2008)
High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins
Cardiovasc Res, 79 (1), 195-203
PubMed 18339644

Solheim S, Seljeflot I, Lunde K, Aukrust P, Yndestad A, Grøgaard HK, Aakhus S, Forfang K, Arnesen H (2008)
Inflammatory responses after intracoronary injection of autologous mononuclear bone marrow cells in patients with acute myocardial infarction
Am Heart J, 155 (1), 55.e1-9
PubMed 18082489

Stanton C, Mookadam F, Cha S, McNamara D, Aukrust P, Wojnicz R, Bailey KR, Cooper LT (2008)
Greater symptom duration predicts response to immunomodulatory therapy in dilated cardiomyopathy
Int J Cardiol, 128 (1), 38-41
PubMed 17707091

Publications 2007

Abedin M, Omland T, Ueland T, Khera A, Aukrust P, Murphy SA, Jain T, Gruntmanis U, McGuire DK, de Lemos JA (2007)
Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study)
Am J Cardiol, 99 (4), 513-8
PubMed 17293196

Arora S, Jenum PA, Aukrust P, Rollag H, Andreassen AK, Simonsen S, Gude E, Fiane AE, Geiran O, Gullestad L (2007)
Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality
J Am Coll Cardiol, 50 (20), 1967-72
PubMed 17996562

Aukrust P, Yndestad A, Damås JK, Ueland T, Øie E, Gullestad L (2007)
Potential mechanisms of benefit with thalidomide in chronic heart failure
Am J Cardiovasc Drugs, 7 (2), 127-34
PubMed 17503883

Aukrust P, Yndestad A, Sandberg WJ, Gullestad L, Damås JK (2007)
T cells in coronary artery disease: different effects of different T-cell subsets
J Am Coll Cardiol, 50 (15), 1459-61
PubMed 17919565

Aukrust P, Yndestad A, Smith C, Ueland T, Gullestad L, Damås JK (2007)
Chemokines in cardiovascular risk prediction
Thromb Haemost, 97 (5), 748-54
PubMed 17479185

Bjerkeli V, Damås JK, Fevang B, Holter JC, Aukrust P, Frøland SS (2007)
Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation
Rheumatology (Oxford), 46 (9), 1422-7
PubMed 17616549

Dahl TB, Yndestad A, Skjelland M, Øie E, Dahl A, Michelsen A, Damås JK, Tunheim SH, Ueland T, Smith C, Bendz B, Tonstad S, Gullestad L, Frøland SS, Krohg-Sørensen K, Russell D, Aukrust P, Halvorsen B (2007)
Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization
Circulation, 115 (8), 972-80
PubMed 17283255

Damås JK, Smith C, Øie E, Fevang B, Halvorsen B, Waehre T, Boullier A, Breland U, Yndestad A, Ovchinnikova O, Robertson AK, Sandberg WJ, Kjekshus J, Taskén K, Frøland SS, Gullestad L, Hansson GK, Quehenberger O, Aukrust P (2007)
Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization
Arterioscler Thromb Vasc Biol, 27 (3), 614-20
PubMed 17170367

Dyrøy E, Røst TH, Pettersen RJ, Halvorsen B, Gudbrandsen OA, Ueland T, Muna Z, Müller F, Nordrehaug JE, Aukrust P, Berge RK (2007)
Tetradecylselenoacetic acid, a PPAR ligand with antioxidant, antiinflammatory, and hypolipidemic properties
Arterioscler Thromb Vasc Biol, 27 (3), 628-34
PubMed 17185614

Fevang B, Yndestad A, Sandberg WJ, Holm AM, Müller F, Aukrust P, Frøland SS (2007)
Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo
Clin Exp Immunol, 147 (3), 521-5
PubMed 17302902

Gullestad L, Oie E, Ueland T, Yndestad A, Aukrust P (2007)
The role of statins in heart failure
Fundam Clin Pharmacol, 21 Suppl 2, 35-40
PubMed 18001320

Halvorsen B, Lund Sagen E, Ueland T, Aukrust P, Tonstad S (2007)
Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease
Scand J Clin Lab Invest, 67 (6), 604-11
PubMed 17852807

Holven KB, Aukrust P, Pedersen TM, Ose L, Nenseter MS (2007)
Enhanced platelet activation in hyperhomocysteinemic individuals
J Thromb Haemost, 5 (1), 193-5
PubMed 17059422

Johansen OE, Birkeland KI, Orvik E, Flesland Ø, Wergeland R, Ueland T, Smith C, Endresen K, Aukrust P, Gullestad L (2007)
Inflammation and coronary angiography in asymptomatic type 2 diabetic subjects
Scand J Clin Lab Invest, 67 (3), 306-16
PubMed 17454845

Omland T, Drazner MH, Ueland T, Abedin M, Murphy SA, Aukrust P, de Lemos JA (2007)
Plasma osteoprotegerin levels in the general population: relation to indices of left ventricular structure and function
Hypertension, 49 (6), 1392-8
PubMed 17470718

Skjelland M, Michelsen AE, Krohg-Sørensen K, Tennøe B, Dahl A, Bakke S, Brosstad F, Damås JK, Russell D, Halvorsen B, Aukrust P (2007)
Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity
Atherosclerosis, 195 (2), e142-6
PubMed 17568588

Wethal T, Kjekshus J, Røislien J, Ueland T, Andreassen AK, Wergeland R, Aukrust P, Fosså SD (2007)
Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer
J Cancer Surviv, 1 (1), 8-16
PubMed 18648940

Yndestad A, Damås JK, Øie E, Ueland T, Gullestad L, Aukrust P (2007)
Role of inflammation in the progression of heart failure
Curr Cardiol Rep, 9 (3), 236-41
PubMed 17470337

Publications 2006

Aukrust P, Yndestad A, Ueland T, Damås JK, Frøland SS, Gullestad L (2006)
The role of intravenous immunoglobulin in the treatment of chronic heart failure
Int J Cardiol, 112 (1), 40-5
PubMed 16893578

Aukrust P, Yndestad A, Ueland T, Damås JK, Gullestad L (2006)
Anti-inflammatory trials in chronic heart failure
Heart Fail Monit, 5 (1), 2-9
PubMed 16547529

Damås JK, Aukrust P (2006)
Systemic markers of inflammation--are they useful predictive tools in coronary artery disease?
Scand Cardiovasc J, 40 (5), 262-6
PubMed 17012135

Damås JK, Jensenius M, Ueland T, Otterdal K, Yndestad A, Frøland SS, Rolain JM, Myrvang B, Raoult D, Aukrust P (2006)
Increased levels of soluble CD40L in African tick bite fever: possible involvement of TLRs in the pathogenic interaction between Rickettsia africae, endothelial cells, and platelets
J Immunol, 177 (4), 2699-706
PubMed 16888032

Florholmen G, Halvorsen B, Beraki K, Lyberg T, Sagen EL, Aukrust P, Christensen G, Yndestad A (2006)
Activin A inhibits organization of sarcomeric proteins in cardiomyocytes induced by leukemia inhibitory factor
J Mol Cell Cardiol, 41 (4), 689-97
PubMed 16926021

Halvorsen B, Waehre T, Scholz H, Damås JK, Yndestad A, Aukrust P (2006)
Role of interleukin-10 in atherogenesis and plaque stabilization
Future Cardiol, 2 (1), 75-83
PubMed 19804134

Haukeland JW, Aukrust P (2006)
Inflammatory interactions between nonalcoholic fatty liver disease and the metabolic syndrome
J. Hepatol., 45 (6), 881-882

Haukeland JW, Damås JK, Konopski Z, Løberg EM, Haaland T, Goverud I, Torjesen PA, Birkeland K, Bjøro K, Aukrust P (2006)
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
J Hepatol, 44 (6), 1167-74
PubMed 16618517

Holm AM, Tjønnfjord G, Yndestad A, Beiske K, Müller F, Aukrust P, Frøland SS (2006)
Polyclonal expansion of large granular lymphocytes in common variable immunodeficiency - association with neutropenia
Clin Exp Immunol, 144 (3), 418-24
PubMed 16734610

Holm T, Ueland T, Halvorsen B, Hognestad A, Holm AG, Wergeland R, Gullestad L, Aukrust P, Kjekshus J (2006)
A protective anti-inflammatory phenotype in high-risk individuals who do not develop coronary artery disease
J Am Coll Cardiol, 47 (5), 1085-6
PubMed 16516099

Holven KB, Aukrust P, Retterstol K, Hagve TA, Mørkrid L, Ose L, Nenseter MS (2006)
Increased levels of C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects
Scand J Clin Lab Invest, 66 (1), 45-54
PubMed 16464786

Holven KB, Damås JK, Yndestad A, Waehre T, Ueland T, Halvorsen B, Heggelund L, Sandberg WJ, Semb AG, Frøland SS, Ose L, Nenseter MS, Aukrust P (2006)
Chemokines in children with heterozygous familiar hypercholesterolemia: selective upregulation of RANTES
Arterioscler Thromb Vasc Biol, 26 (1), 200-5
PubMed 16254204

Holven KB, Halvorsen B, Bjerkeli V, Damås JK, Retterstøl K, Mørkrid L, Ose L, Aukrust P, Nenseter MS (2006)
Impaired inhibitory effect of interleukin-10 on the balance between matrix metalloproteinase-9 and its inhibitor in mononuclear cells from hyperhomocysteinemic subjects
Stroke, 37 (7), 1731-6
PubMed 16728689

Johansen OE, Birkeland KI, Brustad E, Aaser E, Lindahl AK, Midha R, Ueland T, Aukrust P, Gullestad L (2006)
Undiagnosed dysglycaemia and inflammation in cardiovascular disease
Eur J Clin Invest, 36 (8), 544-51
PubMed 16893376

Kvale D, Ormaasen V, Kran AM, Johansson CC, Aukrust P, Aandahl EM, Frøland SS, Taskén K (2006)
Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment
AIDS, 20 (6), 813-20
PubMed 16549964

Otterdal K, Smith C, Oie E, Pedersen TM, Yndestad A, Stang E, Endresen K, Solum NO, Aukrust P, Damås JK (2006)
Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes
Blood, 108 (3), 928-35
PubMed 16861346

Sandberg WJ, Yndestad A, Øie E, Smith C, Ueland T, Ovchinnikova O, Robertson AK, Müller F, Semb AG, Scholz H, Andreassen AK, Gullestad L, Damås JK, Frøland SS, Hansson GK, Halvorsen B, Aukrust P (2006)
Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization
Arterioscler Thromb Vasc Biol, 26 (4), 857-63
PubMed 16424351

Smith C, Damås JK, Otterdal K, Øie E, Sandberg WJ, Yndestad A, Waehre T, Scholz H, Endresen K, Olofsson PS, Halvorsen B, Gullestad L, Frøland SS, Hansson GK, Aukrust P (2006)
Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammation
J Am Coll Cardiol, 48 (8), 1591-9
PubMed 17045893

Ueland T, Aukrust P, Damas JK, Gullestad L, Yndestad A (2006)
The tumor necrosis factor superfamily in heart failure
Future Cardiol, 2 (1), 101-11
PubMed 19804137

Ueland T, Espevik T, Kjekshus J, Gullestad L, Omland T, Squire IB, Frøland SS, Mollnes TE, Dickstein K, Aukrust P (2006)
Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction
J Card Fail, 12 (8), 659-63
PubMed 17045187

Ueland T, Gullestad L, Simonsen S, Endresen K, Scott H, Frøland SS, Geiran O, Fiane AE, Aukrust P (2006)
Decreased endomyocardial RANKL expression in transplant coronary artery disease
Transplantation, 81 (10), 1467-70
PubMed 16732187

Ueland T, Vissers MN, Wiegman A, Rodenburg J, Hutten B, Gullestad L, Ose L, Rifai N, Ridker PM, Kastelein JJ, Aukrust P, Semb AG (2006)
Increased inflammatory markers in children with familial hypercholesterolaemia
Eur J Clin Invest, 36 (3), 147-52
PubMed 16506958

Waehre T, Damås JK, Pedersen TM, Gullestad L, Yndestad A, Andreassen AK, Frøland SS, Semb AG, Hansteen V, Gjertsen E, Ueland T, Brosstad F, Solum NO, Aukrust P (2006)
Clopidogrel increases expression of chemokines in peripheral blood mononuclear cells in patients with coronary artery disease: results of a double-blind placebo-controlled study
J Thromb Haemost, 4 (10), 2140-7
PubMed 16856976

Yndestad A, Damås JK, Oie E, Ueland T, Gullestad L, Aukrust P (2006)
Systemic inflammation in heart failure--the whys and wherefores
Heart Fail Rev, 11 (1), 83-92
PubMed 16819581

Yndestad A, Vinge LE, Bjørnerheim R, Ueland T, Wang JE, Frøland SS, Attramadal H, Aukrust P, Oie E (2006)
Thalidomide attenuates the development of fibrosis during post-infarction myocardial remodelling in rats
Eur J Heart Fail, 8 (8), 790-6
PubMed 16549389

Publications 2005

Aukrust P, Gullestad L, Ueland T, Damås JK, Yndestad A (2005)
Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications
Ann Med, 37 (2), 74-85
PubMed 16026115

Aukrust P, Luna L, Ueland T, Johansen RF, Müller F, Frøland SS, Seeberg EC, Bjørås M (2005)
Impaired base excision repair and accumulation of oxidative base lesions in CD4+ T cells of HIV-infected patients
Blood, 105 (12), 4730-5
PubMed 15705786

Aukrust P, Yndestad A, Smith C, Sandberg WJ, Ueland T, Waehre T, Halvorsen B, Gullestad L, Damås JK (2005)
Potential role for immunomodulatory therapy in atherosclerotic plaque stabilisation
Expert Opin Pharmacother, 6 (13), 2169-80
PubMed 16218879

Aukrust P, Yndestad A, Waehre T, Gullestad L, Halvorsen B, Damås JK (2005)
Inflammation in coronary artery disease: potential role for immunomodulatory therapy
Expert Rev Cardiovasc Ther, 3 (6), 1111-24
PubMed 16293001

Damås JK, Boullier A, Waehre T, Smith C, Sandberg WJ, Green S, Aukrust P, Quehenberger O (2005)
Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy
Arterioscler Thromb Vasc Biol, 25 (12), 2567-72
PubMed 16224053

Damås JK, Puccetti L, Aukrust P (2005)
Early anti-thrombotic and anti-inflammatory actions of statins and fibrates--time for adjuvant therapy in acute coronary syndromes?
Thromb Haemost, 94 (1), 1-3
PubMed 16113777

Dyrøy E, Yndestad A, Ueland T, Halvorsen B, Damås JK, Aukrust P, Berge RK (2005)
Antiinflammatory effects of tetradecylthioacetic acid involve both peroxisome proliferator-activated receptor alpha-dependent and -independent pathways
Arterioscler Thromb Vasc Biol, 25 (7), 1364-9
PubMed 15920037

Fevang B, Mollnes TE, Holm AM, Ueland T, Heggelund L, Damås JK, Aukrust P, Frøland SS (2005)
Common variable immunodeficiency and the complement system; low mannose-binding lectin levels are associated with bronchiectasis
Clin Exp Immunol, 142 (3), 576-84
PubMed 16297171

Fiane AE, Ueland T, Simonsen S, Scott H, Endresen K, Gullestad L, Geiran OR, Haraldsen G, Heggelund L, Andreassen AK, Wergeland R, Frøland S, Aukrust P, Mollnes TE (2005)
Low mannose-binding lectin and increased complement activation correlate to allograft vasculopathy, ischaemia, and rejection after human heart transplantation
Eur Heart J, 26 (16), 1660-5
PubMed 15821010

Glosli H, Gudbrandsen OA, Mullen AJ, Halvorsen B, Røst TH, Wergedahl H, Prydz H, Aukrust P, Berge RK (2005)
Down-regulated expression of PPARalpha target genes, reduced fatty acid oxidation and altered fatty acid composition in the liver of mice transgenic for hTNFalpha
Biochim Biophys Acta, 1734 (3), 235-46
PubMed 15893958

Gullestad L, Aukrust P (2005)
Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches
Am J Cardiol, 95 (11A), 17C-23C; discussion 38C-40C
PubMed 15925560

Gullestad L, Kjekshus J, Damås JK, Ueland T, Yndestad A, Aukrust P (2005)
Agents targeting inflammation in heart failure
Expert Opin Investig Drugs, 14 (5), 557-66
PubMed 15926863

Gullestad L, Ueland T, Fjeld JG, Holt E, Gundersen T, Breivik K, Følling M, Hodt A, Skårdal R, Kjekshus J, Andreassen A, Kjekshus E, Wergeland R, Yndestad A, Frøland SS, Semb AG, Aukrust P (2005)
Effect of thalidomide on cardiac remodeling in chronic heart failure: results of a double-blind, placebo-controlled study
Circulation, 112 (22), 3408-14
PubMed 16301340

Gurantz D, Yndestad A, Halvorsen B, Lunde OV, Omens JH, Ueland T, Aukrust P, Moore CD, Kjekshus J, Greenberg BH (2005)
Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodeling
Cardiovasc Res, 67 (1), 106-15
PubMed 15949474

Halvorsen B, Waehre T, Scholz H, Clausen OP, von der Thüsen JH, Müller F, Heimli H, Tonstad S, Hall C, Frøland SS, Biessen EA, Damås JK, Aukrust P (2005)
Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms
J Lipid Res, 46 (2), 211-9
PubMed 15547296

Heggelund L, Mollnes TE, Espevik T, Müller F, Kristiansen KI, Aukrust P, Frøland SS (2005)
Modulatory effect of mannose-binding lectin on cytokine responses: possible roles in HIV infection
Eur J Clin Invest, 35 (12), 765-70
PubMed 16313253

Hestad KA, Tønseth S, Støen CD, Ueland T, Aukrust P (2005)
Inflammation and depression: further studies are needed
J ECT, 21 (1), 52
PubMed 15791184

Hognestad A, Endresen K, Wergeland R, Mellembakken JR, Mollnes TE, Omland T, Kjekshus JK, Aukrust P, Andreassen AK (2005)
Inflammatory response and re-stenosis after percutaneous coronary intervention in heart transplant recipients and patients with native atherosclerosis
J Heart Lung Transplant, 24 (8), 1026-32
PubMed 16102437

Holm AM, Aukrust P, Damås JK, Müller F, Halvorsen B, Frøland SS (2005)
Abnormal interleukin-7 function in common variable immunodeficiency
Blood, 105 (7), 2887-90
PubMed 15598813

Overland G, Stuestøl JF, Dahle MK, Myhre AE, Netea MG, Verweij P, Yndestad A, Aukrust P, Kullberg BJ, Warris A, Wang JE, Aasen AO (2005)
Cytokine responses to fungal pathogens in Kupffer Cells are Toll-like receptor 4 independent and mediated by tyrosine kinases
Scand J Immunol, 62 (2), 148-54
PubMed 16101821

Scholz H, Sandberg W, Damås JK, Smith C, Andreassen AK, Gullestad L, Frøland SS, Yndestad A, Aukrust P, Halvorsen B (2005)
Enhanced plasma levels of LIGHT in unstable angina: possible pathogenic role in foam cell formation and thrombosis
Circulation, 112 (14), 2121-9
PubMed 16186421

Torheim EA, Yndestad A, Bjerkeli V, Halvorsen B, Aukrust P, Frøland SS (2005)
Increased expression of chemokines in patients with Wegener's granulomatosis - modulating effects of methylprednisolone in vitro
Clin Exp Immunol, 140 (2), 376-83
PubMed 15807865

Ueland T, Aukrust P, Yndestad A, Otterdal K, Frøland SS, Dickstein K, Kjekshus J, Gullestad L, Damås JK (2005)
Soluble CD40 ligand in acute and chronic heart failure
Eur Heart J, 26 (11), 1101-7
PubMed 15716285

Ueland T, Kjekshus J, Frøland SS, Omland T, Squire IB, Gullestad L, Dickstein K, Aukrust P (2005)
Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients
J Am Coll Cardiol, 46 (11), 2018-21
PubMed 16325035

Ueland T, Yndestad A, Øie E, Florholmen G, Halvorsen B, Frøland SS, Simonsen S, Christensen G, Gullestad L, Aukrust P (2005)
Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure
Circulation, 111 (19), 2461-8
PubMed 15883214

Publications 2004

Aukrust P, Damas JK, Solum NO (2004)
Soluble CD40 ligand and platelets: self-perpetuating pathogenic loop in thrombosis and inflammation?
J Am Coll Cardiol, 43 (12), 2326-8
PubMed 15193701

Aukrust P, Yndestad A, Damås JK, Gullestad L (2004)
Therapeutic potential of anticytokine therapy in congestive heart failure
Am J Cardiovasc Drugs, 4 (3), 169-77
PubMed 15134469

Aukrust P, Yndestad A, Damås JK, Gullestad L (2004)
Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulin
Autoimmun Rev, 3 (3), 221-7
PubMed 15110235

Bjerkeli V, Halvorsen B, Damås JK, Nordøy I, Yndestad A, Aukrust P, Frøland SS (2004)
Expression of matrix metalloproteinases in patients with Wegener's granulomatosis
Ann Rheum Dis, 63 (12), 1659-63
PubMed 15547092

Damås JK, Otterdal K, Yndestad A, Aass H, Solum NO, Frøland SS, Simonsen S, Aukrust P, Andreassen AK (2004)
Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells
Circulation, 110 (8), 999-1005
PubMed 15302794

Fredriksen J, Ueland T, Dyrøy E, Halvorsen B, Melby K, Melbye L, Skalhegg BS, Bohov P, Skorve J, Berge RK, Aukrust P, Frøland SS (2004)
Lipid-lowering and anti-inflammatory effects of tetradecylthioacetic acid in HIV-infected patients on highly active antiretroviral therapy
Eur J Clin Invest, 34 (10), 709-15
PubMed 15473896

Heggelund L, Damås JK, Yndestad A, Holm AM, M?ller F, Lien E, Espevik T, Aukrust P, Frøland SS (2004)
Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences
Clin Exp Immunol, 138 (1), 116-21
PubMed 15373913

Heggelund L, Flo T, Berg K, Lien E, Mollnes TE, Ueland T, Aukrust P, Espevik T, Frøland SS (2004)
Soluble toll-like receptor 2 in HIV infection: association with disease progression
AIDS, 18 (18), 2437-9
PubMed 15622324

Heggelund L, Müller F, Lien E, Yndestad A, Ueland T, Kristiansen KI, Espevik T, Aukrust P, Frøland SS (2004)
Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication
Clin Infect Dis, 39 (2), 264-9
PubMed 15307037

Hognestad A, Aukrust P, Wergeland R, Stokke O, Gullestad L, Semb AG, Holm T, Andreassen AK, Kjekshus JK (2004)
Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation
Clin Cardiol, 27 (4), 199-203
PubMed 15119693

Hognestad A, Michelsen A, Brosstad F, Damås JK, Holm T, Simonsen S, Kjekshus JK, Aukrust P, Andreassen AK (2004)
Platelet activation in heart transplant recipients
Clin Transplant, 18 (2), 142-7
PubMed 15016127

Holm AM, Sivertsen EA, Tunheim SH, Haug T, Bjerkeli V, Yndestad A, Aukrust P, Frøland SS (2004)
Gene expression analysis of peripheral T cells in a subgroup of common variable immunodeficiency shows predominance of CCR7(-) effector-memory T cells
Clin Exp Immunol, 138 (2), 278-89
PubMed 15498038

Johansson CC, Bryn T, Yndestad A, Eiken HG, Bjerkeli V, Frøland SS, Aukrust P, Taskén K (2004)
Cytokine networks are pre-activated in T cells from HIV-infected patients on HAART and are under the control of cAMP
AIDS, 18 (2), 171-9
PubMed 15075533

Johansson CC, Bryn T, Aandahl EM, Areklett MA, Aukrust P, Taskén K, Frøland SS (2004)
Treatment with type-2 selective and non-selective cyclooxygenase inhibitors improves T-cell proliferation in HIV-infected patients on highly active antiretroviral therapy
AIDS, 18 (6), 951-2
PubMed 15060445

Johansson CC, Yndestad A, Enserink JM, Ree AH, Aukrust P, Taskén K (2004)
The epidermal growth factor-like growth factor amphiregulin is strongly induced by the adenosine 3',5'-monophosphate pathway in various cell types
Endocrinology, 145 (11), 5177-84
PubMed 15284208

Larsen AI, Gjesdal K, Hall C, Aukrust P, Aarsland T, Dickstein K (2004)
Effect of exercise training in patients with heart failure: a pilot study on autonomic balance assessed by heart rate variability
Eur J Cardiovasc Prev Rehabil, 11 (2), 162-7
PubMed 15187821

Larsson L, Mobini R, Aukrust P, Gullestad L, Wallukat G, Waagstein F, Fu M (2004)
Beneficial effect on cardiac function by intravenous immunoglobulin treatment in patients with dilated cardiomyopathy is not due to neutralization of anti-receptor autoantibody
Autoimmunity, 37 (6-7), 489-93
PubMed 15621576

Laake JH, Bergmann JB, Riddervold F, Bjørneklett A, Aukrust P, Frøland SS (2004)
[Should patients with severe sepsis be treated with activated protein C?]
Tidsskr Nor Laegeforen, 124 (6), 782-4
PubMed 15039808

Scholz H, Aukrust P, Damås JK, Tonstad S, Sagen EL, Kolset SO, Hall C, Yndestad A, Halvorsen B (2004)
8-isoprostane increases scavenger receptor A and matrix metalloproteinase activity in THP-1 macrophages, resulting in long-lived foam cells
Eur J Clin Invest, 34 (7), 451-8
PubMed 15255781

Smith C, Yndestad A, Halvorsen B, Ueland T, Waehre T, Otterdal K, Scholz H, Endresen K, Gullestad L, Frøland SS, Damås JK, Aukrust P (2004)
Potential anti-inflammatory role of activin A in acute coronary syndromes
J Am Coll Cardiol, 44 (2), 369-75
PubMed 15261933

Ueland T, Jemtland R, Godang K, Kjekshus J, Hognestad A, Omland T, Squire IB, Gullestad L, Bollerslev J, Dickstein K, Aukrust P (2004)
Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction
J Am Coll Cardiol, 44 (10), 1970-6
PubMed 15542278

Waehre T, Damås JK, Yndestad A, Taskén K, Pedersen TM, Smith C, Halvorsen B, Frøland SS, Solum NO, Aukrust P (2004)
Effect of activated platelets on expression of cytokines in peripheral blood mononuclear cells - potential role of prostaglandin E2
Thromb Haemost, 92 (6), 1358-67
PubMed 15583745

Waehre T, Yndestad A, Smith C, Haug T, Tunheim SH, Gullestad L, Frøland SS, Semb AG, Aukrust P, Damås JK (2004)
Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors
Circulation, 109 (16), 1966-72
PubMed 15051633

Wang JE, Dahle MK, Yndestad A, Bauer I, McDonald MC, Aukrust P, Foster SJ, Bauer M, Aasen AO, Thiemermann C (2004)
Peptidoglycan of Staphylococcus aureus causes inflammation and organ injury in the rat
Crit Care Med, 32 (2), 546-52
PubMed 14758177

Yndestad A, Ueland T, Øie E, Florholmen G, Halvorsen B, Attramadal H, Simonsen S, Frøland SS, Gullestad L, Christensen G, Damås JK, Aukrust P (2004)
Elevated levels of activin A in heart failure: potential role in myocardial remodeling
Circulation, 109 (11), 1379-85
PubMed 14993131

Publications 2003

Aukrust P, Damås JK, Gullestad L (2003)
Immunomodulating therapy: new treatment modality in congestive heart failure
Congest Heart Fail, 9 (2), 64-9
PubMed 12671336

Aukrust P, Müller F, Svardal AM, Ueland T, Berge RK, Frøland SS (2003)
Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy--potential immunomodulatory effects of antioxidants
J Infect Dis, 188 (2), 232-8
PubMed 12854078

Aukrust P, Wergedahl H, Müller F, Ueland T, Dyrøy E, Damås JK, Frøland SS, Berge RK (2003)
Immunomodulating effects of 3-thia fatty acids in activated peripheral blood mononuclear cells
Eur J Clin Invest, 33 (5), 426-33
PubMed 12713457

Damås JK, Waehre T, Yndestad A, Otterdal K, Hognestad A, Solum NO, Gullestad L, Frøland SS, Aukrust P (2003)
Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets
Circulation, 107 (21), 2670-6
PubMed 12742982

Heggelund L, Mollnes TE, Ueland T, Christophersen B, Aukrust P, Frøland SS (2003)
Mannose-binding lectin in HIV infection: relation to disease progression and highly active antiretroviral therapy
J Acquir Immune Defic Syndr, 32 (4), 354-61
PubMed 12640191

Hestad KA, Tønseth S, Støen CD, Ueland T, Aukrust P (2003)
Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy
J ECT, 19 (4), 183-8
PubMed 14657769

Holm AM, Aukrust P, Aandahl EM, Müller F, Taskén K, Frøland SS (2003)
Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency--involvement of protein kinase A type I
J Immunol, 170 (11), 5772-7
PubMed 12759461

Holm T, Damås JK, Holven K, Nordøy I, Brosstad FR, Ueland T, Währe T, Kjekshus J, Frøland SS, Eiken HG, Solum NO, Gullestad L, Nenseter M, Aukrust P (2003)
CXC-chemokines in coronary artery disease: possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cells
J Thromb Haemost, 1 (2), 257-62
PubMed 12871498

Holven KB, Halvorsen B, Schulz H, Aukrust P, Ose L, Nenseter MS (2003)
Expression of matrix metalloproteinase-9 in mononuclear cells of hyperhomocysteinaemic subjects
Eur J Clin Invest, 33 (7), 555-60
PubMed 12814391

Holven KB, Haugstad TS, Holm T, Aukrust P, Ose L, Nenseter MS (2003)
Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects
Br J Nutr, 89 (3), 359-63
PubMed 12628031

Holven KB, Myhre AM, Aukrust P, Hagve TA, Ose L, Nenseter MS (2003)
Patients with familial hypercholesterolaemia show enhanced spontaneous chemokine release from peripheral blood mononuclear cells ex vivo. Dependency of xanthomas/xanthelasms, smoking and gender
Eur Heart J, 24 (19), 1756-62
PubMed 14522571

Holven KB, Scholz H, Halvorsen B, Aukrust P, Ose L, Nenseter MS (2003)
Hyperhomocysteinemic subjects have enhanced expression of lectin-like oxidized LDL receptor-1 in mononuclear cells
J Nutr, 133 (11), 3588-91
PubMed 14608078

Jensenius M, Ueland T, Fournier PE, Brosstad F, Stylianou E, Vene S, Myrvang B, Raoult D, Aukrust P (2003)
Systemic inflammatory responses in African tick-bite fever
J Infect Dis, 187 (8), 1332-6
PubMed 12696016

Larsen AI, Hall C, Aukrust P, Aarsland T, Faris P, Dickstein K (2003)
Prognostic usefulness of an increase of N-terminal proatrial natriuretic peptide during exercise in patients with chronic heart failure
Am J Cardiol, 92 (1), 91-4
PubMed 12842259

Madebo T, Lindtjørn B, Aukrust P, Berge RK (2003)
Circulating antioxidants and lipid peroxidation products in untreated tuberculosis patients in Ethiopia
Am J Clin Nutr, 78 (1), 117-22
PubMed 12816780

Nordøy I, Rollag H, Lien E, Sindre H, Degré M, Aukrust P, Frøland SS, Müller F (2003)
Cytomegalovirus infection induces production of human interleukin-10 in macrophages
Eur J Clin Microbiol Infect Dis, 22 (12), 737-41
PubMed 14610657

Risnes I, Ueland T, Aukrust P, Lundblad R, Baksaas ST, Mollnes TE, Svennevig JL (2003)
Complement activation and cytokine and chemokines release during mediastinitis
Ann Thorac Surg, 75 (3), 981-5
PubMed 12645727

Risnes I, Ueland T, Lundblad R, Mollnes TE, Baksaas ST, Aukrust P, Svennevig JL (2003)
Changes in the cytokine network and complement parameters during open heart surgery
Interact Cardiovasc Thorac Surg, 2 (1), 19-24
PubMed 17669979

Scholz H, Yndestad A, Damås JK, Waehre T, Tonstad S, Aukrust P, Halvorsen B (2003)
8-isoprostane increases expression of interleukin-8 in human macrophages through activation of mitogen-activated protein kinases
Cardiovasc Res, 59 (4), 945-54
PubMed 14553834

Semb AG, van Wissen S, Ueland T, Smilde T, Waehre T, Tripp MD, Frøland SS, Kastelein JJ, Gullestad L, Pedersen TR, Aukrust P, Stalenhoef AF (2003)
Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy
J Am Coll Cardiol, 41 (2), 275-9
PubMed 12535822

Stylianou E, Bjerkeli V, Yndestad A, Heggelund L, Waehre T, Damås JK, Aukrust P, Frøland SS (2003)
Raised serum levels of interleukin-18 is associated with disease progression and may contribute to virological treatment failure in HIV-1-infected patients
Clin Exp Immunol, 132 (3), 462-6
PubMed 12780693

Ueland T, Kristo C, Godang K, Aukrust P, Bollerslev J (2003)
Interleukin-1 receptor antagonist is associated with fat distribution in endogenous Cushing's syndrome: a longitudinal study
J Clin Endocrinol Metab, 88 (4), 1492-6
PubMed 12679428

Ueland T, Sikkeland LI, Yndestad A, Eiken HG, Holm T, Guevara C, Haug T, Endresen K, Frøland SS, Gullestad L, Andreassen AK, Geiran O, Simonsen S, Aukrust P (2003)
Myocardial gene expression of inflammatory cytokines after heart transplantation in relation to the development of transplant coronary artery disease
Am J Cardiol, 92 (6), 715-7
PubMed 12972116

Waehre T, Damås JK, Gullestad L, Holm AM, Pedersen TR, Arnesen KE, Torsvik H, Frøland SS, Semb AG, Aukrust P (2003)
Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease
J Am Coll Cardiol, 41 (9), 1460-7
PubMed 12742282

Yndestad A, Holm AM, Müller F, Simonsen S, Frøland SS, Gullestad L, Aukrust P (2003)
Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure
Cardiovasc Res, 60 (1), 141-6
PubMed 14522416

Øverland G, Morath S, Yndestad A, Hartung T, Thiemermann C, Foster SJ, Smedsrød B, Mathisen Ø, Aukrust P, Aasen AO, Wang JE (2003)
Lipoteichoic acid is a potent inducer of cytokine production in rat and human Kupffer cells in vitro
Surg Infect (Larchmt), 4 (2), 181-91
PubMed 12906718

Publications 2002

Damås JK, Waehre T, Yndestad A, Ueland T, Müller F, Eiken HG, Holm AM, Halvorsen B, Frøland SS, Gullestad L, Aukrust P (2002)
Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects
Circulation, 106 (1), 36-42
PubMed 12093767

Glosli H, Tronstad KJ, Wergedal H, Müller F, Svardal A, Aukrust P, Berge RK, Prydz H (2002)
Human TNF-alpha in transgenic mice induces differential changes in redox status and glutathione-regulating enzymes
FASEB J, 16 (11), 1450-2
PubMed 12205044

Gullestad L, Semb AG, Holt E, Skårdal R, Ueland T, Yndestad A, Frøland SS, Aukrust P (2002)
Effect of thalidomide in patients with chronic heart failure
Am Heart J, 144 (5), 847-50
PubMed 12422154

Hammer HB, Aukrust P, Frøland SS (2002)
[Churg-Strauss syndrome after treatment with Singulair (montelukast)]
Tidsskr Nor Laegeforen, 122 (5), 484-6
PubMed 11961976

Holm T, Aukrust P, Aagaard E, Ueland T, Haugstad TS, Kjekshus J, Simonsen S, Frøland SS, Gullestad L, Andreassen AK (2002)
Hypertension in relation to nitric oxide, asymmetric dimethylarginine, and inflammation: different patterns in heart transplant recipients and individuals with essential hypertension
Transplantation, 74 (10), 1395-400
PubMed 12451238

Holven KB, Aukrust P, Holm T, Ose L, Nenseter MS (2002)
Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects
Arterioscler Thromb Vasc Biol, 22 (4), 699-703
PubMed 11950713

Kristo C, Godang K, Ueland T, Lien E, Aukrust P, Froland SS, Bollerslev J (2002)
Raised serum levels of interleukin-8 and interleukin-18 in relation to bone metabolism in endogenous Cushing's syndrome
Eur J Endocrinol, 146 (3), 389-95
PubMed 11888846

Larsen AI, Lindal S, Aukrust P, Toft I, Aarsland T, Dickstein K (2002)
Effect of exercise training on skeletal muscle fibre characteristics in men with chronic heart failure. Correlation between skeletal muscle alterations, cytokines and exercise capacity
Int J Cardiol, 83 (1), 25-32
PubMed 11959380

Liabakk NB, Sundan A, Torp S, Aukrust P, Frøland SS, Espevik T (2002)
Development, characterization and use of monoclonal antibodies against sTRAIL: measurement of sTRAIL by ELISA
J Immunol Methods, 259 (1-2), 119-28
PubMed 11730847

Mellembakken JR, Aukrust P, Olafsen MK, Ueland T, Hestdal K, Videm V (2002)
Activation of leukocytes during the uteroplacental passage in preeclampsia
Hypertension, 39 (1), 155-60
PubMed 11799095

Müller F, Tjønnfjord GE, Nordøy I, Kvale D, Mellbye OJ, Aukrust P, Frøland SS (2002)
Immunophenotypic analyses of CD34(+) cell subsets in bone marrow from HIV-infected patients during highly- active antiretroviral therapy
Eur J Clin Invest, 32 (7), 535-40
PubMed 12153555

Stylianou E, Yndestad A, Sikkeland LI, Bjerkeli V, Damås JK, Haug T, Eiken HG, Aukrust P, Frøland SS (2002)
Effects of interferon-alpha on gene expression of chemokines and members of the tumour necrosis factor superfamily in HIV-infected patients
Clin Exp Immunol, 130 (2), 279-85
PubMed 12390316

Waehre T, Halvorsen B, Damås JK, Yndestad A, Brosstad F, Gullestad L, Kjekshus J, Frøland SS, Aukrust P (2002)
Inflammatory imbalance between IL-10 and TNFalpha in unstable angina potential plaque stabilizing effects of IL-10
Eur J Clin Invest, 32 (11), 803-10
PubMed 12423320

Yndestad A, Damås JK, Geir Eiken H, Holm T, Haug T, Simonsen S, Frøland SS, Gullestad L, Aukrust P (2002)
Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure
Cardiovasc Res, 54 (1), 175-82
PubMed 12062373

Publications 2001

Aukrust P, Berge RK, Ueland T, Aaser E, Damås JK, Wikeby L, Brunsvig A, Müller F, Forfang K, Frøland SS, Gullestad L (2001)
Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes
J Am Coll Cardiol, 37 (2), 485-91
PubMed 11216967

Aukrust P, Damås JK, Gullestad L, Frøland SS (2001)
Chemokines in myocardial failure -- pathogenic importance and potential therapeutic targets
Clin Exp Immunol, 124 (3), 343-5
PubMed 11472392

Aukrust P, Gullestad L, Lappegård KT, Ueland T, Aass H, Wikeby L, Simonsen S, Frøland SS, Mollnes TE (2001)
Complement activation in patients with congestive heart failure: effect of high-dose intravenous immunoglobulin treatment
Circulation, 104 (13), 1494-500
PubMed 11571242

Aukrust P, Gullestad L, Aass H, Fjeld JG, Wikeby L, Andreassen AK, Ihlen H, Simonsen S, Kjekshus J, Nitter-Hauge S, Ueland T, Froland SS (2001)
Increase in anti-inflammatory cytokine levels in chronic heart failure: A measure of treatment success or failure? Response
Circulation, 104 (18), E97-E98

Aukrust P, Waehre T, Damås JK, Gullestad L, Solum NO (2001)
Inflammatory role of platelets in acute coronary syndromes
Heart, 86 (6), 605-6
PubMed 11711447

Damås JK, Aukrust P, Ueland T, Odegaard A, Eiken HG, Gullestad L, Sejersted OM, Christensen G (2001)
Monocyte chemoattractant protein-1 enhances and interleukin-10 suppresses the production of inflammatory cytokines in adult rat cardiomyocytes
Basic Res Cardiol, 96 (4), 345-52
PubMed 11518190

Damås JK, Gullestad L, Aukrust P (2001)
Cytokines as new treatment targets in chronic heart failure
Curr Control Trials Cardiovasc Med, 2 (6), 271-277
PubMed 11806813

Damås JK, Gullestad L, Aass H, Simonsen S, Fjeld JG, Wikeby L, Ueland T, Eiken HG, Frøland SS, Aukrust P (2001)
Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure--modulatory effect of intravenous immunoglobulin
J Am Coll Cardiol, 38 (1), 187-93
PubMed 11451272

Eiken HG, Øie E, Damås JK, Yndestad A, Bjerkeli V, Aass H, Simonsen S, Geiran OR, Tønnessen T, Christensen G, Frøland SS, Gullestad L, Attramadal H, Aukrust P (2001)
Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failure
Eur J Clin Invest, 31 (5), 389-97
PubMed 11380590

Gullestad L, Aukrust P (2001)
The cytokine network in heart failure: pathogenetic importance and potential therapeutic targets
Heart Fail Monit, 2 (1), 8-13
PubMed 12634893

Gullestad L, Ueland T, Brunsvig A, Kjekshus J, Simonsen S, Frøland SS, Aukrust P (2001)
Effect of metoprolol on cytokine levels in chronic heart failure--a substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HF)
Am Heart J, 141 (3), 418-21
PubMed 11231439

Gullestad L, Aass H, Andreassen AK, Ihlen H, Simonsen S, Kjekshus J, Wikeby L, Nitter-Hauge S, Fjeld JG, Lien E, Ueland T, Frøland SS, Aukrust P (2001)
[Immunomodulating treatment in advanced heart failure--effect of intravenous immunoglobulin]
Tidsskr Nor Laegeforen, 121 (16), 1902-7
PubMed 11488180

Gullestad L, Aass H, Fjeld JG, Wikeby L, Andreassen AK, Ihlen H, Simonsen S, Kjekshus J, Nitter-Hauge S, Ueland T, Lien E, Frøland SS, Aukrust P (2001)
Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure
Circulation, 103 (2), 220-5
PubMed 11208680

Helle SI, Ueland T, Ekse D, Frøland SS, Holly JM, Lønning PE, Aukrust P (2001)
The insulin-like growth factor system in human immunodeficiency virus infection: relations to immunological parameters, disease progression, and antiretroviral therapy
J Clin Endocrinol Metab, 86 (1), 227-33
PubMed 11232005

Holm T, Andreassen AK, Aukrust P, Andersen K, Geiran OR, Kjekshus J, Simonsen S, Gullestad L (2001)
Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients
Eur Heart J, 22 (5), 428-36
PubMed 11207085

Holm T, Andreassen AK, Ueland T, Kjekshus J, Frøland SS, Kjekshus E, Simonsen S, Aukrust P, Gullestad L (2001)
Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients
Am J Cardiol, 87 (6), 815-8, A9
PubMed 11249916

Holm T, Berge RK, Andreassen AK, Ueland T, Kjekshus J, Simonsen S, Frøland S, Gullestad L, Aukrust P (2001)
Omega-3 fatty acids enhance tumor necrosis factor-alpha levels in heart transplant recipients
Transplantation, 72 (4), 706-11
PubMed 11544435

Holven KB, Holm T, Aukrust P, Christensen B, Kjekshus J, Andreassen AK, Gullestad L, Hagve TA, Svilaas A, Ose L, Nenseter MS (2001)
Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects
Am J Med, 110 (7), 536-42
PubMed 11343667

Larsen AI, Aukrust P, Aarsland T, Dickstein K (2001)
Effect of aerobic exercise training on plasma levels of tumor necrosis factor alpha in patients with heart failure
Am J Cardiol, 88 (7), 805-8
PubMed 11589856

Mellembakken JR, Aukrust P, Hestdal K, Ueland T, Abyholm T, Videm V (2001)
Chemokines and leukocyte activation in the fetal circulation during preeclampsia
Hypertension, 38 (3), 394-8
PubMed 11566911

Mellembakken JR, Solum NO, Ueland T, Videm V, Aukrust P (2001)
Increased concentrations of soluble CD40 ligand, RANTES and GRO-alpha in preeclampsia--possible role of platelet activation
Thromb Haemost, 86 (5), 1272-6
PubMed 11816717

Pettersen RJ, Muna ZA, Kuiper KK, Svendsen E, Müller F, Aukrust P, Berge RK, Nordrehaug JE (2001)
Sustained retention of tetradecylthioacetic acid after local delivery reduces angioplasty-induced coronary stenosis in the minipig
Cardiovasc Res, 52 (2), 306-13
PubMed 11684079

Stylianou E, Aukrust P, Müller F, Nordøy I, Frøland SS (2001)
Complex effects of interferon-alpha on the cytokine network in HIV infection--possible contribution to immunosuppression
Cytokine, 14 (1), 56-62
PubMed 11298493

Ueland T, Bollerslev J, Godang K, Müller F, Frøland SS, Aukrust P (2001)
Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess--possible role in bone homeostasis
Eur J Endocrinol, 145 (6), 685-90
PubMed 11720891

Ueland T, Frøland SS, Bollerslev J, Aukrust P (2001)
Increased levels of biochemical markers of bone turnover in relation to persistent immune activation in common variable immunodeficiency
Eur J Clin Invest, 31 (1), 72-8
PubMed 11168441

Publications 2000

Aukrust P, Bjørnsen S, Lunden B, Otterdal K, Ng EC, Ameln W, Ueland T, Müller F, Solum NO, Brosstad F, Frøland SS (2000)
Persistently elevated levels of von Willebrand factor antigen in HIV infection. Downregulation during highly active antiretroviral therapy
Thromb Haemost, 84 (2), 183-7
PubMed 10959687

Aukrust P, Müller F, Ueland T, Svardal AM, Berge RK, Frøland SS (2000)
Decreased vitamin A levels in common variable immunodeficiency: vitamin A supplementation in vivo enhances immunoglobulin production and downregulates inflammatory responses
Eur J Clin Invest, 30 (3), 252-9
PubMed 10692003

Damås JK, Eiken HG, Oie E, Bjerkeli V, Yndestad A, Ueland T, Tonnessen T, Geiran OR, Aass H, Simonsen S, Christensen G, Froland SS, Attramadal H, Gullestad L, Aukrust P (2000)
Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure
Cardiovasc Res, 47 (4), 778-87
PubMed 10974226

Damås JK, Gullestad L, Ueland T, Solum NO, Simonsen S, Frøland SS, Aukrust P (2000)
CXC-chemokines, a new group of cytokines in congestive heart failure--possible role of platelets and monocytes
Cardiovasc Res, 45 (2), 428-36
PubMed 10728363

Holm T, Aukrust P, Andreassen AK, Ueland T, Brosstad F, Frøland SS, Simonsen S, Gullestad L (2000)
Peripheral endothelial dysfunction in heart transplant recipients: possible role of proinflammatory cytokines
Clin Transplant, 14 (3), 218-25
PubMed 10831080

Jacobsen MB, Aukrust P, Kittang E, Müller F, Ueland T, Bratlie J, Bjerkeli V, Vatn MH (2000)
Relation between food provocation and systemic immune activation in patients with food intolerance
Lancet, 356 (9227), 400-1
PubMed 10972377

Müller F, Svardal AM, Nordoy I, Berge RK, Aukrust P, Frøland SS (2000)
Virological and immunological effects of antioxidant treatment in patients with HIV infection
Eur J Clin Invest, 30 (10), 905-14
PubMed 11029606

Nordøy I, Müller F, Nordal KP, Rollag H, Aukrust P, Frøland SS (2000)
Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infection
Clin Exp Immunol, 120 (2), 333-7
PubMed 10792384

Nordøy I, Müller F, Nordal KP, Rollag H, Lien E, Aukrust P, Froland SS (2000)
The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients
J Infect Dis, 181 (1), 51-7
PubMed 10608750

Stylianou E, Aukrust P, Bendtzen K, Müller F, Frøland SS (2000)
Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection
Clin Exp Immunol, 119 (3), 479-85
PubMed 10691920

Stylianou E, Aukrust P, Nordøy I, Müller F, Frøland SS (2000)
Enhancement of lymphocyte proliferation induced by interleukin-12 and anti-interleukin-10 in HIV-infected patients during highly active antiretroviral therapy
APMIS, 108 (9), 601-7
PubMed 11110048

Taskén K, Hansson V, Aukrust P, Frøland S, Skålhegg BS, Müller F, Tobin D, Vang T, Torgersen KM, Aandahl EM (2000)
PKAI as a potential target for therapeutic intervention
Drug News Perspect, 13 (1), 12-8
PubMed 12937648

Publications 1999

Aukrust P, Gullestad L, Frøland SS (1999)
Is apoptosis an important pathogenic factor in cardiovascular disease?
Eur J Clin Invest, 29 (5), 369-71
PubMed 10354192

Aukrust P, Haug CJ, Ueland T, Lien E, Müller F, Espevik T, Bollerslev J, Frøland SS (1999)
Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy
J Clin Endocrinol Metab, 84 (1), 145-50
PubMed 9920075

Aukrust P, Müller F (1999)
Glutathione redox disturbances in human immunodeficiency virus infection: immunologic and therapeutic consequences
Nutrition, 15 (2), 165-7
PubMed 9990587

Aukrust P, Müller F, Lien E, Nordoy I, Liabakk NB, Kvale D, Espevik T, Froland SS (1999)
Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure
J Infect Dis, 179 (1), 74-82
PubMed 9841825

Aukrust P, Müller F, Svenson M, Nordøy I, Bendtzen K, Frøland SS (1999)
Administration of intravenous immunoglobulin (IVIG) in vivo--down-regulatory effects on the IL-1 system
Clin Exp Immunol, 115 (1), 136-43
PubMed 9933433

Aukrust P, Müller F, Ueland T, Berget T, Aaser E, Brunsvig A, Solum NO, Forfang K, Frøland SS, Gullestad L (1999)
Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes
Circulation, 100 (6), 614-20
PubMed 10441098

Aukrust P, Ueland T, Lien E, Bendtzen K, Müller F, Andreassen AK, Nordøy I, Aass H, Espevik T, Simonsen S, Frøland SS, Gullestad L (1999)
Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
Am J Cardiol, 83 (3), 376-82
PubMed 10072227

Aukrust P, Aandahl EM, Skålhegg BS, Nordøy I, Hansson V, Taskén K, Frøland SS, Müller F (1999)
Increased activation of protein kinase A type I contributes to the T cell deficiency in common variable immunodeficiency
J Immunol, 162 (2), 1178-85
PubMed 9916750

Gullestad L, Aukrust P, Ueland T, Espevik T, Yee G, Vagelos R, Frøland SS, Fowler M (1999)
Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure
J Am Coll Cardiol, 34 (7), 2061-7
PubMed 10588224

Gullestad L, Simonsen S, Ueland T, Holm T, Aass H, Andreassen AK, Madsen S, Geiran O, Frøland SS, Aukrust P (1999)
Possible role of proinflammatory cytokines in heart allograft coronary artery disease
Am J Cardiol, 84 (9), 999-1003
PubMed 10569653

Kvale D, Aukrust P, Osnes K, Müller F, Frøland SS (1999)
CD4+ and CD8+ lymphocytes and HIV RNA in HIV infection: high baseline counts and in particular rapid decrease of CD8+ lymphocytes predict AIDS
AIDS, 13 (2), 195-201
PubMed 10202825

Nordøy I, Müller F, Nordal KP, Rollag H, Lien E, Aukrust P, Frøland SS (1999)
Immunologic parameters as predictive factors of cytomegalovirus disease in renal allograft recipients
J Infect Dis, 180 (1), 195-8
PubMed 10353879

Stylianou E, Aukrust P, Kvale D, Müller F, Frøland SS (1999)
IL-10 in HIV infection: increasing serum IL-10 levels with disease progression--down-regulatory effect of potent anti-retroviral therapy
Clin Exp Immunol, 116 (1), 115-20
PubMed 10209514

Torfoss D, Aukrust P, Brinch L, Mathiesen O, Simonsen GS, Axelsen AK, Gaustad P (1999)
Carrier rate of resistant enterococci in a tertiary care hospital in Norway
APMIS, 107 (6), 545-9
PubMed 10379681

Aandahl EM, Aukrust P, Müller F, Hansson V, Taskén K, Frøland SS (1999)
Additive effects of IL-2 and protein kinase A type I antagonist on function of T cells from HIV-infected patients on HAART
AIDS, 13 (17), F109-14
PubMed 10597771

Publications 1998

Andreassen AK, Nordøy I, Simonsen S, Ueland T, Müller F, Frøland SS, Gullestad L, Aukrust P (1998)
Levels of circulating adhesion molecules in congestive heart failure and after heart transplantation
Am J Cardiol, 81 (5), 604-8
PubMed 9514458

Aukrust P, Müller F, Frøland SS (1998)
Circulating levels of RANTES in human immunodeficiency virus type 1 infection: effect of potent antiretroviral therapy
J Infect Dis, 177 (4), 1091-6
PubMed 9534990

Aukrust P, Ueland T, Müller F, Andreassen AK, Nordøy I, Aas H, Kjekshus J, Simonsen S, Frøland SS, Gullestad L (1998)
Elevated circulating levels of C-C chemokines in patients with congestive heart failure
Circulation, 97 (12), 1136-43
PubMed 9537339

Haug CJ, Aukrust P, Haug E, Mørkrid L, Müller F, Frøland SS (1998)
Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis
J Clin Endocrinol Metab, 83 (11), 3832-8
PubMed 9814454

Haug CJ, Müller F, Aukrust P, Frøland SS (1998)
Different effect of 1,25-dihydroxyvitamin D3 on replication of Mycobacterium avium in monocyte-derived macrophages from human immunodeficiency virus-infected subjects and healthy controls
Immunol Lett, 63 (2), 107-12
PubMed 9761372

Holme PA, Müller F, Solum NO, Brosstad F, Frøland SS, Aukrust P (1998)
Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection
FASEB J, 12 (1), 79-89
PubMed 9438413

Lien E, Aukrust P, Sundan A, Müller F, Frøland SS, Espevik T (1998)
Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events
Blood, 92 (6), 2084-92
PubMed 9731066

Müller F, Aukrust P, Lien E, Haug CJ, Frøland SS (1998)
Enhanced interleukin-10 production in response to Mycobacterium avium products in mononuclear cells from patients with human immunodeficiency virus infection
J Infect Dis, 177 (3), 586-94
PubMed 9498436

Müller F, Aukrust P, Nordoy I, Froland SS (1998)
Possible role of interleukin-10 (IL-10) and CD40 ligand expression in the pathogenesis of hypergammaglobulinemia in human immunodeficiency virus infection: modulation of IL-10 and Ig production after intravenous Ig infusion
Blood, 92 (10), 3721-9
PubMed 9808566

Nordøy I, Müller F, Aukrust P, Frøland SS (1998)
Adhesion molecules in common variable immunodeficiency (CVID)--a decrease in L-selectin-positive T lymphocytes
Clin Exp Immunol, 114 (2), 258-63
PubMed 9822285

Aandahl EM, Aukrust P, Skålhegg BS, Müller F, Frøland SS, Hansson V, Taskén K (1998)
Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patients
FASEB J, 12 (10), 855-62
PubMed 9657525

Publications 1997

Aukrust P, Berge RK, Müller F, Ueland PM, Svardal AM, Frøland SS (1997)
Elevated plasma levels of reduced homocysteine in common variable immunodeficiency--a marker of enhanced oxidative stress
Eur J Clin Invest, 27 (9), 723-30
PubMed 9352241

Aukrust P, Hestdal K, Lien E, Bjerkeli V, Nordøy I, Espevik T, Müller F, Frøland SS (1997)
Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-alpha activity in human immunodeficiency virus type 1 infection
J Infect Dis, 176 (4), 913-23
PubMed 9333149

Aukrust P, Müller F, Nordøy I, Haug CJ, Frøland SS (1997)
Modulation of lymphocyte and monocyte activity after intravenous immunoglobulin administration in vivo
Clin Exp Immunol, 107 (1), 50-6
PubMed 9010256

Hestdal K, Aukrust P, Müller F, Lien E, Bjerkeli V, Espevik T, Frøland SS (1997)
Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load
Blood, 90 (7), 2670-9
PubMed 9326234

Publications 1996

Aukrust P, Lien E, Kristoffersen AK, Müller F, Haug CJ, Espevik T, Frøland SS (1996)
Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency--possible immunologic and clinical consequences
Blood, 87 (2), 674-81
PubMed 8555490

Aukrust P, Svardal AM, Müller F, Lunden B, Nordøy I, Frøland SS (1996)
Markedly disturbed glutathione redox status in CD45RA+CD4+ lymphocytes in human immunodeficiency virus type 1 infection is associated with selective depletion of this lymphocyte subset
Blood, 88 (7), 2626-33
PubMed 8839856

Haug CJ, Aukrust P, Lien E, Müller F, Espevik T, Frøland SS (1996)
Disseminated Mycobacterium avium complex infection in AIDS: immunopathogenic significance of an activated tumor necrosis factor system and depressed serum levels of 1,25 dihydroxyvitamin D
J Infect Dis, 173 (1), 259-62
PubMed 8537672

Haug CJ, Müller F, Rollag H, Aukrust P, Degré M, Frøland SS (1996)
The effect of 1,25-vitamin D3 on maturation of monocytes from HIV-infected patients varies with degree of immunodeficiency
APMIS, 104 (7-8), 539-48
PubMed 8920807

Hestad K, Aukrust P, Ellertsen B, Kløve H (1996)
Neuropsychological deficits in HIV-1 seropositive and seronegative intravenous drug users (IVDUs): a follow-up study
J Int Neuropsychol Soc, 2 (2), 126-33
PubMed 9375197

Müller F, Svardal AM, Aukrust P, Berge RK, Ueland PM, Frøland SS (1996)
Elevated plasma concentration of reduced homocysteine in patients with human immunodeficiency virus infection
Am J Clin Nutr, 63 (2), 242-8
PubMed 8561066

Nordøy I, Aukrust P, Müller F, Frøland SS (1996)
Abnormal levels of circulating adhesion molecules in HIV-1 infection with characteristic alterations in opportunistic infections
Clin Immunol Immunopathol, 81 (1), 16-21
PubMed 8808636

Ueland PM, Mansoor MA, Guttormsen AB, Muller F, Aukrust P, Refsum H, Svardal AM (1996)
Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status - A possible element of the extracellular antioxidant defense system
J. Nutr., 126 (4 S), S1281-S1284

Ueland PM, Mansoor MA, Guttormsen AB, Müller F, Aukrust P, Refsum H, Svardal AM (1996)
Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status--a possible element of the extracellular antioxidant defense system
J Nutr, 126 (4 Suppl), 1281S-4S
PubMed 8642471

Publications 1995

Aukrust P, Liabakk NB, Müller F, Espevik T, Frøland SS (1995)
Activation of tumor necrosis factor--alpha system in HIV-1 infection: association with markers of immune activation
Infection, 23 (1), 9-15
PubMed 7744500

Aukrust P, Svardal AM, Müller F, Lunden B, Berge RK, Frøland SS (1995)
Decreased levels of total and reduced glutathione in CD4+ lymphocytes in common variable immunodeficiency are associated with activation of the tumor necrosis factor system: possible immunopathogenic role of oxidative stress
Blood, 86 (4), 1383-91
PubMed 7632946

Aukrust P, Svardal AM, Müller F, Lunden B, Berge RK, Ueland PM, Frøland SS (1995)
Increased levels of oxidized glutathione in CD4+ lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection
Blood, 86 (1), 258-67
PubMed 7795231

Müller F, Aukrust P, Nilssen DE, Frøland SS (1995)
Reduced serum level of transforming growth factor-beta in patients with IgA deficiency
Clin Immunol Immunopathol, 76 (2), 203-8
PubMed 7614739

Publications 1994

Aukrust P, Frøland SS, Liabakk NB, Müller F, Nordøy I, Haug C, Espevik T (1994)
Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo
Blood, 84 (7), 2136-43
PubMed 7919327

Aukrust P, Liabakk NB, Müller F, Lien E, Espevik T, Frøland SS (1994)
Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection--correlations to clinical, immunologic, and virologic parameters
J Infect Dis, 169 (2), 420-4
PubMed 7906293

Aukrust P, Müller F, Frøland SS (1994)
Enhanced generation of reactive oxygen species in monocytes from patients with common variable immunodeficiency
Clin Exp Immunol, 97 (2), 232-8
PubMed 8050170

Aukrust P, Müller F, Frøland SS (1994)
Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodeficiency (CVI) are associated with chronic immune activation and low numbers of CD4+ lymphocytes
Clin Immunol Immunopathol, 70 (3), 217-24
PubMed 7906214

HAUG C, MULLER F, AUKRUST P, FROLAND SS (1994)
HIV infection and abnormal vitamin D metabolism: Serum levels of 1,25-vitamin D correlates with clinical progression, survival and markers of immunodeficiency
VITAMIN D: PLURIPOTENT STEROID HORMONE: STRUCTURAL STUDIES, MOLECULAR ENDOCRINOLOGY AND CLINICAL APPLICATIONS, 912-913

Haug C, Müller F, Aukrust P, Frøland SS (1994)
Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival
J Infect Dis, 169 (4), 889-93
PubMed 7907645

Hestad K, Aukrust P, Ellertsen B, Kløve H (1994)
Psychological difficulties related to human immunodeficiency virus-1 infection in intravenous drug users
Acta Psychiatr Scand, 90 (1), 25-31
PubMed 7976445

Müller F, Frøland SS, Aukrust P, Fagerhol MK (1994)
Elevated serum calprotectin levels in HIV-infected patients: the calprotectin response during ZDV treatment is associated with clinical events
J Acquir Immune Defic Syndr, 7 (9), 931-9
PubMed 7914232

PEDERSEN TR, KJEKSHUS J, BERG K, HAGHFELT T, FAERGEMAN O, THORGEIRSSON G, PYORALA K, MIETTINEN T, WILHELMSEN L, OLSSON AG, WEDEL H, KRISTIANSON K, THOMSEN H, NORDERO E, THOMSEN B, LYNGBORG K, ANDERSEN GS, NIELSEN F, TALLERUPHUUS U, MCNAIR A, EGSTRUP K, SIMONSEN EH, SIMONSEN I, VEJBYCHRISTENSEN H, SOMMER L et al. (1994)
RANDOMIZED TRIAL OF CHOLESTEROL-LOWERING IN 4444 PATIENTS WITH CORONARY-HEART-DISEASE - THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S)
Lancet, 344 (8934), 1383-1389

Publications 1993

Hestad K, Aukrust P, Ellertsen B, Kløve H, Wilberg K (1993)
Neuropsychological deficits in HIV-1 seropositive and seronegative intravenous drug users
J Clin Exp Neuropsychol, 15 (5), 732-42
PubMed 8276932

Nilssen DE, Aukrust P, Frøland SS, Müller F, Fausa O, Halstensen TS, Brandtzaeg P (1993)
Duodenal intraepithelial gamma/delta T cells and soluble CD8, neopterin, and beta 2-microglobulin in serum of IgA-deficient subjects with or without IgG subclass deficiency
Clin Exp Immunol, 94 (1), 91-8
PubMed 8403524

Publications 1992

Aukrust P, Farstad IN, Frøland SS, Holter E (1992)
Cytomegalovirus (CMV) pneumonitis in AIDS patients: the result of intensive CMV replication?
Eur Respir J, 5 (3), 362-4
PubMed 1315296

Aukrust P, Frøland SS, Müller F (1992)
Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features
Clin Exp Immunol, 89 (2), 211-6
PubMed 1638765

Moum B, Aukrust P, Schrumpf E, Mørk T, Mathisen O, Elgjo K (1992)
[Natural products can be hazardous to health]
Tidsskr Nor Laegeforen, 112 (10), 1308-11
PubMed 1579916

Mølstad P, Smith G, Aukrust P (1992)
Left atrial myxoma and systemic AL-amyloidosis
Eur Heart J, 13 (1), 143-4
PubMed 1577023

Publications 1991

Aukrust P, Frøland SS, Kvale D, Egge K, Farstad IN, Holter E, Moum B (1991)
[Symptomatic cytomegalovirus infection in patients with acquired immunodeficiency syndrome]
Tidsskr Nor Laegeforen, 111 (28), 3379-84
PubMed 1665253

Aukrust P, Moum B, Farstad IN, Holter E, Bjørneklett A, Kremer D (1991)
Fatal cytomegalovirus (CMV) colitis in a patient receiving low dose prednisolone therapy
Scand J Infect Dis, 23 (4), 495-9
PubMed 1659739

Moum B, Aukrust P, Bjørneklett A, Frøland SS, Farstad IN, Holter E (1991)
[Cytomegalovirus disease in the gastrointestinal tract]
Tidsskr Nor Laegeforen, 111 (28), 3388-91
PubMed 1665255

Moum B, Aukrust P, Fausa O, Farstad IN, Holter E (1991)
[Cytomegalovirus disease in the upper gastrointestinal tract. Endoscopic findings]
Tidsskr Nor Laegeforen, 111 (28), 3391-3
PubMed 1665256

Publications 1990

Aukrust P (1990)
[Acyclovir-resistant herpes simplex virus]
Tidsskr Nor Laegeforen, 110 (21), 2770-3
PubMed 2171155

Publications 1989

Aukrust P, Abeler V (1989)
[Intestinal spirochaetosis]
Tidsskr Nor Laegeforen, 109 (6), 698-9
PubMed 2922737

Aukrust P, Haugtomt H (1989)
[Viral or bacterial meningitis. Differential diagnostic problems]
Tidsskr Nor Laegeforen, 109 (4), 448-50
PubMed 2919375

Aukrust P, Haugtomt H (1989)
[Herpes simplex virus infection of the central nervous system]
Tidsskr Nor Laegeforen, 109 (4), 451-3
PubMed 2919376

Aukrust P, Hestad K (1989)
[HIV and the central nervous system]
Tidsskr Nor Laegeforen, 109 (23), 2298-302
PubMed 2772897

Publications 1988

Aukrust P, Torp R, Bjønnes J (1988)
[Vasculitis of the central nervous system]
Tidsskr Nor Laegeforen, 108 (33), 3094-6
PubMed 3206499